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SUMMARY 
 
The mammalian cerebral cortex receives consistent projections of cholinergic and 
non-cholinergic neurons from the basal forebrain (BF). Different structures and 
nuclei have been historically included in the BF by different authors, including the 
medial septum, the horizontal and vertical limbs of the Broca diagonal band (HDB 
and VDB, respectively), the substancia innominata and the nucleus Basal 
magnocellular (B nucleus, Meynert basal magnocellular nucleus in humans). BF 
structures provide the major source of cholinergic innervation to the sensory, 
motor and prefrontal cortex (mPfC), and to the hippocampus, which exert 
extensive modulatory actions on mood and cognition. Specific reciprocal 
projections between different BF nuclei and their cortical targets are necessary to 
control the sensory information processed in the different cortices. Cholinergic 
cortical innervation plays a fundamental role in the processes of attention, 
learning, memory and in the processing of sensory information. The cholinergic 
hypothesis of Alzheimer's disease (AD) arose from evidence of loss of cholinergic 
markers in the cortex. The loss of neuronal cholinergic projections in AD causes 
severe disorders in learning, memory and sensory processing, which are the main 
causes of disability in patients, all of them showing extensive neuronal loss. The 
deregulation of some of the process where TDP-43 is implicated might lead to an 
abberant aggregation and modification of TDP-43 in the affected cells. 
 The aim of this Thesis is, firstly, to elucidate if different neuronal 
populations of BF modulate specific sensitive cortical areas through separate 
neural networks, and, second, to study the possible involvement of these BF 
circuits in AD, which may be altered by neuronal loss, or by cellular toxicity 
hypothesis as the cause of such neuronal death. For these purposes, anatomical 
techniques of neural tracing were used in rodents by injecting retrograde and 
anterograde tracers into cortical areas and in different BF nuclei that were 
combined with sensory and optogenetic stimulation to determine the functionality 
of the different reciprocal pathways between BF and the cortical areas. Cell culture 
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methods were also used to study the possible cellular toxicity by studying TDP-43 
function. Anatomic and optogenetic results indicate that while VDB/HDB exhibit 
more specific cortical targets, B nucleus shows wider non-specific targets in the 
cortex. In addition, the VDB/HDB comprises reciprocal projections to the mPfC and 
sensory cortices. Although the B nucleus is involved in the projection to sensory 
pathways, it does not project to mPfC. We also observed a loss of neurons in the 
HDB in the case of APP/PS1 mice accompanied by increased expression of the IGF1 
receptor in their cholinergic neurons. Therefore, we can conclude that the B 
nucleus does not present specific circuits for the different cortices but presents a 
non-specific pattern of projections and does not show a B nucleus-mPfC 
connecting circuit, which could mean that this nucleus does not play a decisive role 
in sensory input discrimination. Conversely, the cholinergic projection of HDB may 
be important in AD during the early stages of its development due to the specific 
neuronal projection circuit patterns present in this nucleus and linked to the 
greater expression of IGF1 present in its cholinergic neurons, which might be 
exerting a protective effect on them. 
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RESUMEN 
 
 La corteza cerebral de los mamíferos recibe proyecciones consistentes de 
las neuronas colinérgicas y no-colinérgicas desde el prosencéfalo basal (BF). 
Diferentes estructuras y núcleos han sido históricamente incluidos en el BF por 
diferentes autores, entre ellos están el septo medial, los brazos horizontal y 
vertical de la banda diagonal de Broca (HDB y VDB, respectivamente), la sustancia 
innominada (SI) y el núcleo basal magnocelular (Núcleo B, núcleo magnocelular 
basal de Meynert en humanos). Las estructuras del BF proporcionan la mayor 
fuente de inervación colinérgica a las cortezas sensoriales, motora y prefrontal, y al 
hipocampo, que ejercen amplias acciones moduladoras sobre el estado de ánimo y 
la cognición. Proyecciones recíprocas específicas entre diferentes estructuras del 
BF y sus dianas corticales son necesarias para controlar la información sensorial 
procesada en las diferentes cortezas. La inervación cortical  colinérgica desempeña 
un papel fundamental en los procesos de atención, aprendizaje, memoria y en el 
procesamiento de la información sensorial. La hipótesis colinérgica de la 
Enfermedad de Alzheimer (EA), surgió a partir de evidencias de pérdida de 
marcadores colinérgicos en la corteza. La pérdida de neuronas y proyecciones 
colinérgicas en la EA provoca graves trastornos en el aprendizaje, la memoria y el 
procesamiento sensorial, que son las principales causas de discapacidad en los 
pacientes. La desregulación de algunos de los procesos en los que está implicado el 
TDP-43, cuyo papel en relación con EA está siendo estudiado actualmente, podría 
estar implicada en la agregación y modificación de TDP-43 en las células afectadas.  
 Los objetivo de esta Tesis son, en primer lugar, elucidar si diferentes 
poblaciones neuronales del BF modulan áreas corticales sensitivas específicas a 
través de redes neuronales independientes, y, en segundo lugar, estudiar la posible 
implicación de estos circuitos en la EA, que se puedan ver alterados por pérdida 
neuronal, o por toxicidad celular como causa de muerte neuronal. Para estos 
propósitos se utilizaron técnicas anatómicas de trazado neuronal en roedores por 
medio de la inyección de trazadores retrógrados y anterógrados en áreas corticales 
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y en diferentes núcleos del BF que se combinaron con estimulación sensorial y 
optogenética para determinar la funcionalidad de las diferentes vías recíprocas 
entre el BF y las áreas corticales.  Se emplearon métodos de cultivo celular para 
estudiar la posible toxicidad celular por pérdida de función del TDP-43. Los 
resultados anatómicos y optogenéticos indican que mientras, VDB/HDB tienen 
objetivos corticales más específicos, el núcleo B no presenta dianas específicas a la 
corteza. El VDB/HDB mantiene proyecciones recíprocas a las cortezas prefrontal 
medial (mPfC)  y somatosensoriales. Aunque el núcleo B está involucrado en la 
proyección a  vías somatosensoriales, no proyecta a mPfC. También se observó una 
pérdida de neuronas en el HDB en el caso de ratones APP/PS1 acompañado de una 
mayor expresión del receptor de IGF1 en sus neuronas colinérgicas. Con todos 
estos datos, podemos concluir que el núcleo B no presenta circuitos específicos 
para las distintas cortezas, sino que presenta un patrón inespecífico de 
proyecciones y no muestra un circuito núcleo B-mPfC. Esto podría significar que 
éste núcleo no desempeña un papel decisivo en la discriminación de la entrada 
sensorial. En contraposición, la proyección colinérgica de HDB podría ser 
importante en las primeras etapas de la EA debido a que sus patrones de 
proyección neuronal específicos podrían estar ejerciendo bajo un efecto protector 
del IGF1 mediado por su mayor expresión en las neuronas colinérgicas. 
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1. INTRODUCTION 
1.1. BASAL FOREBRAIN 
 
 The basal forebrain (BF) is a brain region located, as its name indicates, in 
the basal part of the forebrain. It includes several structures distributed al along 
the brain from rostral to caudal. A global and detailed Knowledge of the neuronal 
connectivity, as well as of the central nervous system is crucial for the well 
understanding of how the brain Works, both in physiological and pathological 
conditions.The mammalian cerebral cortex receives consistent projections from 
cholinergic and non-cholinergic neurons in the BF.  
 
Many classic classifications of the BF have been done based on different 
criteria such as anatomy, citoarchitectonic, biochemical features or 
electrophysiological properties. 
 
From an anatomical point of view, we have followed the classification that 
Kristt et al did in 1985, where he divided the BF fibers in 3 pathways: 
1) Anterior pathway: In sagittal sections fiber bundles can be traced 
from the SI / B region to the frontal cortex. After passing through the neoestriatum 
the fibers cross the outer capsule and curl dorsally to enter the VI layer of the 
frontal cortex. Another small group of AChE-rich fibers that runs dorso-ventrally 
anterior to the neo-striatum appear to attach to a major trajectory before entering 
the cortex. This second path could be originated in the hypothalamus, according to 
retrograde transport data. The entry point in the cortex of all fascicles is close to 
the transition zone with the olfactory cortex. 
2) Medial pathway: The existence of a medial pathway rich in AChE in 
rat was histologically described by Shute and Lewis. Emerging from the AChE rich 
sums in the HDB is a bundle of fibers with a dorso-lateral course and entering layer 
VI of the anterior medial cortex, area 24. In this sheet the fibers continue dorsally 
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in a coronal plane Tilted 10-20º rostrally. Additional fibers of a more caudal and / 
or mid-lateral origin seem to attach to the medial bundle, probably outside of HDB 
(as for example SI). These fibers of the medial bundle disappear from the coronal 
plane as it approaches the back of the minor forceps. In sagittal planes, the beam is 
rotated caudally and continues along the deep margin of the medial cortex above 
the corpus callosum. In horizontal sections these fibers seem to extend to reach the 
cingular cortex and also within of the medial parts of the occipital cortex. 
3) Lateral pathway: Seems to innervate the frontal-lateral, parieto-
temporal and latero-occipital cortex. With B and SI as a concentrator, there are 
groups of fibers that flow into temporal, parietal and frontal fields in an elaborate 
three-dimensional variety. Most fibers pass sequentially through the balloon, 
neoestriatum, and the outer capsule. Commonly, upon entering layer VI of the 
fronto-parietal cortex, these "striatal radiations" seem to turn abruptly dorsum-
medially in the plane of entry. In sagittal sections passing tangentially through 
layer VI of the fronto-parietal cortex, this pivot point appears as a dense horizontal 
band from which individual fibers emerge. At levels progressively more caudal or 
rostral to the fronto-parietal cortex no beams of direct connection with the B / SI 
nucleus can be traced, not even in immature animals. In contrast, numerous short 
segments of AChE positive fibers are found between the microstructure (or the 
outer capsule) and the layer VI of the cortex. This can be interpreted as an 
indication that at caudal and rostral levels in the lateral cortex the BF afferents 
enter the cortex at relatively acute angles. Some fibers rich in AChE follow a 
dorsomedial course from the neoestriado, probably to innervate the cortical 
regions in the proximity of the cíngulo, where they could partially overlap with the 
territory of the medial path. The medial occipital cortex is innervated from the 
anterior SI and the HDB. This can be explained in terms of the spatial distribution 
of the medial path. Fibers in this path cross these anterior regions of the BF with 
the cx both cingular and occipital-medial. The other regions in the postero-lateral 
cortex of the rat that are innervated by caudal regions of the nucleus B surely 
receive inputs via the lateral pathway. 
In three dimensions, the fibers constitute a structure like that of a leaf, 
connecting the anterior BF with the polar cortex. The fibers of the lateral path 
radiate multidirectionally. Similarly, lateral fibers enter the cortex and rotate 
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dorsally within the plane of entry. The anterior fibers that penetrate the cortex 
rotate 90 ° medially and out of the plane of entry. The anterior fibers that 
penetrate the cortex rotate 90º medially and out of the plane of entry. The 
topography of the fibers in each system cannot be duplicated simply by rotating 
the subcortical portion of the lateral fibers or above, a second rotation is necessary 
to be topographically congruent. For example, lateral and medial pathways seem to 
innervate medial regions of the occipital cortex. Medial injections of the tracer to 
this area are expected to retrograde HDB neurons, whereas more lateral injections 
may reveal marked neurons in later parts of B nucleus (Kristt, et al 1985). 
 
From a biochemical point of view based on the classification of Mesulam of 
1983 we can make a classification of the neurons in 6 groups (Figure 1.1). 
There is an organization of ascending cholinergic projections: the BF and 
the brainstem in the rat, which contain six groups of cholinergic projection 
neurons, designated Ch1-Ch6 based on cytoarchitectonic criteria and connectivity 
patterns. Since ChAT is the most specific marker for cholinergic neurons, it can be 
said that the projections to the neocortex, olfactory bulb, hippocampus and 
thalamus arise, at least in part, from the cholinergic cell bodies of Ch1-Ch6. 
Pharmacological experiments showed that most cortical cholinergic innervation 
was extrinsic and originated in the subcortical cholinergic neurons of BF and 
reticular formation. 
In the rat brain, the Ch1-Ch2 sectors are contained within the medial 
septum and VDB, respectively. They provide the main cholinergic projection to 
hippocampus formation. The Ch3 sector is mostly contained within the lateral side 
of the HDB and provides the main cholinergic projection to the olfactory bulb. The 
Ch4 sector contains the cholinergic neurons of nucleus B, the SI and probably also 
neurons located laterally of VDB. One criterion for unification of Ch4 is that its 
components provide the main cholinergic innervation to neo-cortical targets. Ch4 
mainly innervates the amygdala. The Ch5-Ch6 sectors are located in the 
pontomesencephalic reticular formation and provide the main cholinergic 
innervation to the thalamus. There is overlap in connectivity whereby individual 
sectors of Ch also provide a smaller source of cholinergic innervation for areas 
other than their main targets. The cortical mantle is under a dual cholinergic 
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influence. On the one hand, there is a monosynaptic corticopetal cholinergic 
pathway that comes mainly from Ch4. On the other hand, there is also an indirect 
pathway that has a cholinergic segment from Ch5-Ch6 to the thalamus and a non-
cholinergic segment from the thalamus to the cortex. 
 
 
      
 
Figure 1.1: Schematic drawing of Mesulam classification (1983) of 
cholinergic neurons, Ch1-Ch6 groups. 
 
 We can also make a classification of BF neurons based on 
electrophysiological criteria. BF cholinergic neurons can be subdivided into two 
populations based on their trigger times in response to depolarizing currents. 
Therefore, we refer to them as early-firing (EF) that constitute 70% of the 
neuronal population present in the BF, and late-firing (LF) neurons that make up 
the remaining 30%. EF neurons discharge at higher frequencies in response to 
intracellular injections of current, but this is accompanied by a prominent ear of 
adaptive frequency. In many cases, these neurons stop firing after an initial 
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discharge. On the other hand, LF neurons are less excitable, but are able to 
maintain a tonic firing pattern in response to longer (10 second) injections of 
current. This heterogeneity is achieved through an intricate role between different 
voltage-mediated calcium and K conductance’s (Unal et al 2015). 
 
Different authors have included distinct structures and nuclei the BF which 
are distributed from rostral to caudal all over the brain. It is formed of several 
heterogeneous structures, which include, depending on the author, the following 
nuclei: the medial septum, the horizontal and vertical limbs of the diagonal band of 
Broca (HDB and VDB, respectively), the substantia innominata (SI), the extended 
amigdala, subpalial regions and the nucleus basalis magnocellularis (B nucleus, or 
in humans, Maynert basal magnocellular nucleus). These nuclei are conformed of a 
broad variety of neurons of different biochemical characteristics; they contain 
gabaergic, cholinergic and glutamatergic projecting neurons, as well as 
interneurons. These structures provide most of the cholinergic innervation to 
sensory, motor and prefrontal cortices and the hippocampus (Houser et al., 1985; 
Semba and Fibiger, 1989; Mesulam et al., 1992; Gritti et al., 1997; Semba, 2000; 
Bloem et al., 2014; Zaborszky et al., 2015; Kim et al., 2016). There is abundant 
evidence that the BF cortical projections play an essential role in cognitive 
functions such as attention states, learning and memory, wakefulness and 
processing of sensory information (e.g. Manns et al., 2001; Broussard et al., 2009, 
Sarter et al., 2014; Zant et al., 2016). 
 
Anatomical studies have indicated the existence of a highly structured and 
topographic organization of BF efferent projections to sensory cortices (Zaborszky, 
2002; Zaborszky et al., 2005, 2015). The above-mentioned authors propose that 
cholinergic and non-cholinergic projections to the neocortex are not diffuse but are 
instead organized into segregated or overlapped neuronal groups (Zaborszky et al., 
2015). Rodent studies of the anatomical pathways linking the BF with primary 
somatosensory (S1), auditory (A1) and visual (V1) cortical areas studied have 
shown that separate or partially overlapping groups of BF neurons display specific 
projection pathways to primary sensory cortices of different modalities (Zaborsky 
et al., 2015; Chaves-Coira et al., 2016). In the same way, the rostro caudal 
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distribution of retrogradely-labeled neurons in BF shows that neurons projecting 
to the medial prefrontal cortex (mPfC) tended to cluster in the rostral portion of 
the BF region (Chandler et al., 2013). Moreover, cholinergic pathways originated in 
different BF nuclei have been described following four different routes, depending 
on their location, to reach different layers of the mPfC (Bloem et al., 2014). The 
mPfC is a brain region involved in a wide range of diseases. It maintains a large 
number of connections to other cortical and subcortical regions (Groenewegen et 
al 1997) and should act as a control station, integrating information it receives 
from numerous structures and sending this updated or integrated information to 
target structures (Miller and Cohen, 2001). Consistent with this organization of 
anatomical pathways, optogenetic activation of cholinergic neurons in BF 
subnuclei induces modality-selective desynchronization in specific sensory 
cortices (Kim et al., 2016) and sensory modulation (Chaves-Coira et al., 2016). 
Moreover, projections from the prefrontal cortex to the BF have been observed 
(Zaborszky et al., 1997) and posited to contribute to the top-down regulation of 
this area.  
 
Despite many studies on the relations between the location of different BF 
nuclei and their projection areas, the question of how specific these projections are 
and how precisely different regions in the BF map on their cortical targets are still 
unanswered. 
 
 
1.2 Acetylcholine  
As mentioned above, the BF constitues the main source of ACh to the cortex.  
Acetylcholine (ACh) is essential to normal central nervous system (CNS) function, 
modulating the activity of the thalamocortical network in many important brain 
functions, such as arousal (e.g., (Buzsaki et al., 1988, Détári, 2000, Szymusiak et al., 
2000, Lee et al., 2004, Goard and Dan, 2009), attention (Chiba et al., 1999, Sarter et 
al., 2003), learning (Wilson and Rolls, 1990a, b) and memory ((Pauli and O'Reilly, 
2008, Hasselmo and Sarter, 2011, Luchicchi et al., 2014, Sarter et al., 2014). 
Moreover, ACh enhances synaptic plasticity in the hippocampus (e.g. (Doralp and 
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Leung, 2008, Fernandez de Sevilla et al., 2008, Navarrete et al., 2012)) and 
neocortex (e.g. (Metherate and Ashe, 1993, Kuo et al., 2009, Bueno-Junior et al., 
2012, Nuñez et al., 2012, Barros-Zulaica et al., 2014). 
 
Ach is a simple molecule synthesized from choline and acetyl-CoA (Figure 
1.2) by the action of choline acetyltransferase. The neurons that synthesize and 
release Ach are called cholinergic neurons. 
Figure 1.2: Acetylcholine molecule representation 
 
 
When an action potential reaches the terminal button of a pre-synaptic 
neuron a calcium channel opens. The entry of calcium ions stimulates the 
exocytosis of the presynaptic vesicles containing Ach, which is consequently 
released into the synaptic gap. Once released, the Ach is carried out by the enzyme 
acetylcholinesterase. Acetylcholinesterase, which is found in the nerve terminals, 
is anchored to plasma membranes through a glycolipid. Ach receptors are cation 
channels composed of four disperse polypeptide subunits (alpha2 beta gamma). 
Two major classes of Ach receptors have been identified: muscarinic receptors and 
nicotinic receptors. Both kinds of receptors exist with abundance in the human. 
Nicotinic receptors are eventually divided into receptors found in neuromuscular 
junctions and those found in neuronal synapses. Activation of Ach receptors by 
binding to their ligand leads to sodium intake to the cell and K+ output, resulting in 
depolarization of the post-synaptic neuron and initiation of a new action potential. 
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The synthesis of ACh involves the reaction of choline with acetyl co-enzyme 
A. Much of the choline used in this process is recycled but it can also be 
synthesized de novo in the neurone. This reaction is catalysed by the enzyme 
choline acetyltransferase (Figure 1.3). Once ACh has combined with the receptor 
site, it must be rapidly removed from the synapse for repolarisation to occur. It is 
therefore catalyzed by the enzyme acetylcholinesterase to produce choline and 
acetate. As previously mentioned the choline is then recycled back into the 
terminal to produce new molecules of ACh. 
 
 
Figure 1.3: Eschematic Ach cycle representation in a synapsis. 
 
 
Cortical ACh plays an important role in cortical awakening, attention, 
learning and memory, and BF cholinergic neurons are the main source of Ach to 
the cerebral cortex (Rasmusson, 2000; Semab 2000). Cholinergic innervation of 
the neocortex derives primarily from BF and has been proposed to play a key role 
in cognitive functions in humans. 
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This function seems to require a diffuse organized innervation to integrate 
the activity on different regions of the neocortex. Although this innervation rich in 
AchE has a diffuse distribution, several observations suggest that individual 
neurons in BF must interact with a relatively limited population of cortical 
neurons. Proximal clusters, intranuclear axonal collaterals exhibiting BF neurons 
must be particularly relevant in this regard (Donald A et al 1985). 
 
In the CNS, Ach transmission is mainly guaranteed by dense innervation of 
select cortical and subcortical regions from disperse groups of cholinergic neurons 
within the basal forebrain (BF) and the pontine-mesencephalic nuclei, respectively. 
The BF contains a diverse population of neurons, including cortically projecting 
cholinergic and non-cholinergic neurons as well as various interneurons 
(Zaborszky et al., 2012). The BF includes the medial septum, horizontal and 
vertical limbs of the diagonal band of Broca (HDB and VDB, respectively), the 
substantia innominata (SI), as well as the nucleus basalis magnocellularis (B), 
which provide the majority of the cholinergic innervation to the sensory, motor 
and prefrontal cortices and to the hippocampus (Semba and Fibiger, 1989, 
Zaborszky et al., 2012, Eckenstein et al., 1988, Lysakowski et al., 1989). However, 
newer evidence concerning the BF system indicates the existence of a highly 
structured and topographic organization of efferent projections to sensory cortices 
(Zaborszky, 2002, Golmayo et al., 2003, Zaborszky et al., 2005, Zaborszky et al., 
2013). The above mentioned authors propose that cholinergic and non-cholinergic 
projections to the neocortex are not diffuse, but instead, are organized into 
segregated or overlapping neuronal groups (Zaborszky et al., 2013). Consequently, 
previous results suggest a refined anatomical and functional topographical 
organization of the BF corticopetal projection system that may control cortical 
sensory processing in a specific manner. Studies measuring cortical ACh level have 
demonstrated that visual stimulation causes much greater ACh release in visual 
cortex than in non-visual cortical areas (Collier and Mitchell, 1966; Fournier et al., 
2004; Laplante et al., 2005). Anatomical tracing methods have not revealed any 
extensive projections from sensory relay nuclei to the BF (Semba et al., 1988; 
Záborszky et al., 1991). Thus, it has been proposed that sensory information 
arrives to the BF through cortico-cortical projections from primary cortical 
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sensory areas via the prefrontal cortex (Záborszky et al., 1997). Results from either 
electrophysiological recordings (Golmayo et al. 2003) or inactivation of the 
prefrontal cortex (Rasmusson et al., 2007) have demonstrated that the prefrontal 
cortex is necessary for sensory-evoked cortical ACh release. These results strongly 
support the proposed specific circuit –sensory cortex to prefrontal cortex to basal 
forebrain –for each sensory modality. 
 
 
1.3 Alzheimer Desease  
Alzheimer’s disease (AD) is considered a progressive neurodegenerative 
disorder with an estimated 5.3 million patients of all ages in the United States of 
America (Hebert et al 2013). AD is acknowledged as the most common leading 
cause of dementia in late adult life. It is associated with cerebral cortical atrophy 
and neuropathology hallmark of the disease are neurofibrillary tangles and 
amyloid protein deposits contributing to plaques. The senile plaques are composed 
of insoluble aggregates of Aβ peptides, which are derived from the amyloid 
precursor protein (APP) via cleavage by the protease, β- and γ-secretase (De 
Strooper 2010;  Rajendran and Annaert 2012). Two different forms are 
established, based on the onset of first symptoms and presumed pathogenesis. 
Early-onset AD is a term used for uncommon, accounting for only 2-5% of all 
Alzheimer’s cases and is diagnosed before the age of 65. Approximately 15% of the 
early-onset cases are familial, where a genetic predisposition leads to the disease 
(Mendez 2012). In contrast, most cases of AD do not exhibit genetic inheritance 
and are termed sporadic AD. The pathophysiology of late-onset AD remains only 
partly understood, but some environmental and genetic differences may be 
associated as risk factors. 
 
Given its prominent role in regulating attention and memory circuits, 
cholinergic signaling is a key player in mediating cognitive performance. The 
cholinergic hypothesis of AD emerged from evidences of loss of cholinergic 
markers in the cortex (Geula and Mesulam, 1989), loss of the number of neurons in 
the BF (Whitehouse et al., 1982), and the recent report of a volume loss in the 
nucleus basalis of Meynert (Cantero et al., 2016). Although AD is most classically 
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associated with memory deficits, these deficits are typically conflated with 
attention issues (Romberg et al., 2013). Nevertheless, both, the sensory-motor 
deficits and arousal decline, also appear later in AD patients. This progression in 
AD symptoms may be due to the heterogeneity of the BF nuclei and their specific 
projections. As we will describe, some BF areas are involved in the sensory 
processing that is required for attention, memory and learning processes, sensory-
motor coordination, or promotion of arousal. Thus, heterogenic cholinergic 
neuronal loss may also occur in different BF structures in the course of the disease 
and our understanding of these structures requires much work. 
 
 
1.4 IGF1 
 The insulin-like growth factor 1 (IGF-1) receptor is a protein found on the 
surface of human cells (Figure 1.5). It is a transmembrane receptor that is 
activated by a hormone called insulin-like growth factor 1 (IGF-1) (Figure 1.4) and 
by a related hormone called IGF-2. It belongs to the large class of tyrosine kinase 
receptors. This receptor mediates the effects of IGF-1, which is a polypeptide 
protein hormone similar in molecular structure to insulin. IGF-1 plays an 
important role in growth and continues to have anabolic effects in adults – 
meaning that it can induce hypertrophy of skeletal muscle and other target tissues. 
Mice lacking the IGF-1 receptor die late in development, and show a dramatic 
reduction in body mass, testifying to the strong growth-promoting effect of this 
receptor. Mice carrying only one functional copy of IGF-1R are normal, but exhibit 
a ~15% decrease in body mass. 
 
 
 
 
 
 
Figure 1.4: Molecular structure of IGF1 protein. 
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Two alpha subunits and two beta subunits make up the IGF-1 receptor. Both 
the α and β subunits are synthesized from a single mRNA precursor. The precursor 
is then glycosylated, proteolytically cleaved, and crosslinked by cysteine bonds to 
form a functional transmembrane αβ chain (Gregory et al 2001). The α chains are 
located extracellularly, while the β subunit spans the membrane and is responsible 
for intracellular signal transduction upon ligand stimulation. The mature IGF-1R 
has a molecular weight of approximately 320 kDa. The receptor is a member of a 
family which consists of the insulin receptor and the IGF-2R (and their respective 
ligands IGF-1 and IGF-2), along with several IGF-binding proteins. 
 
The IGF-1R and the insulin receptor both have a binding site for ATP, which 
is used to provide the phosphates for auto phosphorylation. There is a 60% 
homology between IGF-1R and the insulin receptor. 
In response to ligand binding, the α chains induce the tyrosine auto 
phosphorylation of the β chains. This event triggers a cascade of intracellular 
signaling that, while cell type-specific, often promotes cell survival and cell 
proliferation (Jones and Clemmons 1995) (LeRoith et al 1995). The structures of 
the auto phosphorylation complexes of tyrosine residues 1165 and 1166 have 
been identified within crystals of the IGF1R kinase domain (Xu et al 2015). 
 
 
Figure 1.5: Schematic diagram of the IGF-1R structure. 
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 Studies in female mice have shown that both supraoptic nucleus and 
paraventricular nucleus lose approximately one-third of IGF-1R immunoreactive 
cells with normal aging. Also, old calorically restricted (CR) mice lost higher 
numbers of IGF-1R non-immunoreactive cells while maintaining similar counts of 
IGF-1R immunoreactive cells in comparison to old-Al mice. Consequently, old-CR 
mice show a higher percentage of IGF-1R immunoreactive cells, reflecting 
increased hypothalamic sensitivity to IGF-1 in comparison to normally aging mice 
(Saeed et al 2007) (Yaghmaie et al 2006). 
It is now clear that the pleiotropic neurotrophic factor IGF-I also 
modulates cognition and mood (Fernandez and Torres-Aleman 2012).  
 
Cholinergic neurons in BF, which exert wide modulatory actions on mood 
and cognition (Lin et al 2015), are profusely connected to mPfC (Bloem et al 2014) 
neurons. The BF receives connections form the prefrontal cortex and sends 
projections to the entire cortex (Semba 2000). Cholinergic innervation of the 
cerebral cortex plays a fundamental role in attention, learning, memory and 
sensory information processing. Loss of this cholinergic projection in AD provokes 
severe disorders in learning, memory, and sensory processing, which are major 
causes of disability in the patients, showing all of them extensive neuronal loss 
(Bondareff et al 1982; Whitehouse et al 1982).  
   Multidirectional relationships between IGF-I and neurotransmitter 
systems such as Ach are hinted by many observations. IGF-I is also known to 
modulate cholinergic function (Knusel et al 1990). Other indirect evidence adds 
further support to the notion that IGF-I and Ach may work in concert. IGF-I 
facilitates sensory processing in the cortex and enhances EEG activity (Trueba et al 
2013; Nishijima et al 2010), and BF cholinergic neurons induce cortical activation 
and facilitates sensory processing (Oldford and Castro-Alamancos 2003; Sarter et 
al 2009). 
Indeed, profound cholinergic disturbances are a hallmark of AD 
(Whitehouse et al 1982), while recent data hint to also a disturbed IGF-I function 
(Carro and Torres-Aleman 2004; Talbot et al 2012) in AD pathology.  
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1.5 TDP-43. Cell culture experiments.   
 Recently, the role of TDP43 in AD has become intensively studied. The 
TARDBP gene provides instructions for making a protein called transactive 
response DNA binding protein 43 kDa (TDP-43). This protein is found within the 
cell nucleus in most tissues and is involved in many of the steps of protein 
production. It is cytogenetic located at 1p36.22, which is the short (p) arm of 
chromosome 1 at position 36.22 and its molecular location is: base pairs 11,012,622 
to 11,030,528 on chromosome 1 (Homo sapiens Annotation Release 108, 
GRCh38.p7) (Figure 1.4). 
 
 
Figure 1.4: TDP-43 gene location. 
 
 
 The TARDBP gene is expressed during early development before birth when 
new tissues are forming. Many of the proteins whose production is influenced by 
the TDP-43 protein are involved in nervous system and organ development. 
 
 TDP43 was initially desribed as a transcriptional repressor that binds to 
chromosomally integrated TAR DNA. In particular, TDP-43 is a splicing factor 
binding to the intron2/exon3 region of the apoA-II gene (Kuo et al 2009). TDP-43 
has been shown to bind both DNA and RNA and have multiple functions in 
transcriptional repression. Further roles has been included recently, such as 
regulator of splicing, pre-mRNA splicing, mRNA stability, microRNA processing, 
translational regulation, mRNA transport and translation (Ayala 2011; Buratti 
2010; Kawahara  and Mieda-Sato 2012). 
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 Recent work has characterized the transcriptome-wide binding sites 
revealing that thousands of RNAs are bound by TDP-43 in neurons (Sephton et al 
2011).  
 Dysregulation of many of these processes might precede the abberant 
aggregation and modification of TDP43 in affected cells. A hyper-phosphorylated, 
ubiquitinated and cleaved form of TDP-43—known as pathologic TDP43—is the 
major disease protein in ubiquitin-positive, tau-, and alpha-synuclein-negative 
frontotemporal dementia (Mackenzie et al 2011) and in Amyotrophic lateral 
sclerosis(ALS) (Neumann et al 2006). Elevated levels of the TDP-43 protein have 
also been identified in individuals diagnosed with chronic traumatic 
encephalopathy a condition that often mimics ALS and that has been associated 
with athletes who have experienced multiple concussions and other types of head 
injury (Schwarz et al 2011). Abnormalities of TDP-43 also occur in an important 
subset of AD patients, correlating with clinical and neuropathologic features 
indexes (Tremblay et al 2011). Moreover, TDP-43 pathology has been detected in 
25-50% of all AD cases, especially those with severe clinical phenotype, and the 
presence of TDP-43 neuronal and glial inclusions is estimated to be approximately 
25-30% (Uryu et al 2008). 
 
 Mutations in the TARDBP gene are associated with neurodegenerative 
disorders. TDP43 is the major component of neuronal inclusions in ALS and 
frontotemporal lobar degeneration (FTLD). Cytoplasmic TDP-43 pathology is the 
dominant histopathological feature of multisystem proteinopathy (Kim et al 2013). 
The N-terminal domain, which contributes importantly to the aggregation of the C-
terminal region, has a novel structure with two negatively charged loops 
(Mompean et al 2016). 
For all the mentioned above, including the lack of unanimity in the 
agreement of an unique BF classification between the different authors, the fact of 
historically / classically description assuming that the projections, to and from the 
BF, are diffuse and ipsilateral to the cortices, and the importance of the functions in 
which BF is implicated, also its cholinergic neurons, which are implicated  in 
diverse neurodegenerative diseases, we decided to study the connection patterns 
between different nuclei of the BF and the A1, V1, S1 and mPfC circuits, both in 
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control animals (rats and mice) as in an Alzheimer's Disease model such as the 
APP/PS1 mouse. On the other hand, we were interested in studying the possible 
involvement of IGF1 and TDP-43 in the AD in terms of neuronal toxicity, since we 
hypothesized whether some of the AD symptoms could be a consequence of the 
neuronal loss occurring in BF nuclei or if they may be a gain of neuronal toxicity 
which leads to a loss of function in the circuits. 
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Hypotheses & Objectives 
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2. HYPOTHESIS AND OBJECTIVES 
 
2.1 MAIN HYPOTHESIS 
The BF has been classically characterized as a diffuse structure since no 
neuronal groups have been well defined, and numerous projecting and passing-by 
fibers run across it. Moreover, the BF is a heterogeneous structure and its neuronal 
components display a wide variety of biochemical phenotypes. Across the scientific 
literature, authors have described different constitutive structures of this region. 
Many functions had been attributed to the BF nuclei such as attention, cognition, 
learning and memory, sleep-wake cycle, motivational states and, language skills. 
However, there is not yet a consensus on how authors characterize and classify 
this heterogeneous region and their connections to other brain structures.  
Despite many studies on the relationship between the location of different 
BF nuclei and their cortical projection, the question of how specific these 
projections are and how precisely different nuclei are in the BF map on their 
cortical targets are still unanswered. 
Our hypothesis is: the specificity of anatomical pathways linking the BF 
nuclei with the cerebral cortex, as well as their functional roles may play an 
important role since it has been hypothesized that AD symptoms may be a 
consequence of either neuronal loss or impairment of BF neurons functionality due 
to toxicity.  
 
 
2.2 GENERAL AND SPECIFIC AIMS 
 Aim 1: To anatomically trace the potential projecting pathways linking 
different BF nuclei and distinct cerebral cortices. 
 
1.1 To delineate the potential specific neuronal groups in the BF involved in the 
control of specific sensory cortices. For this aim, fluorescent retrograde 
neuronal tracers were injected/deposited in the sensory cortices of rats, 
and in C57 control and transgenic mice in order to identify the BF neurons 
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projecting to these cortices. Optogenetic stimulation methods were used in 
the transgenic mice in order to validate the anatomical findings. 
 
1.2 To determine the existence and characteristic features of the neural 
networks linking different sensory cortices with the BF nuclei. For this aim, 
fluorescent neuronal tracers and viral vectors were injected in the BF nuclei 
of rat and mice, in order to detect the projections from these cortices to the 
BF nuclei. Optogenetic stimulation methods were used in order to validate 
the anatomical results. 
 
1.3 To investigate the involvement of motor and prefrontal cortices in these 
networks. For this aim, retrograde fluorescent neuronal tracers were 
injected in both motor and prefrontal cortices in rat and mice.  
 
1.4 To compare the projection pathway of these BF-cortical networks in control 
and APP/PS1 mice. For this aim, two different fluorescent neuronal tracers 
were injected the BF nuclei and cortices of APP/PS1 mice.  
 
 Aim 2: To analyze the biochemical features of the BF neurons that give 
rise to these pathways. For this aim, different immunohistochemistry 
methods and optogenetic techniques were used in C57 control and 
transgenic mice. 
 
 
 Aim 3: To identify the location of IGF-1 receptors in the BF nuclei of C57 
control and of APP/PS1 Alzheimer mice model to investigate its possible 
implication in the pathogenesis of AD. For this aim 
immunohistochemistry methods were used. 
 
 
 Aim 4: To study the effect of TDP-43 knockout in BV2 cells and primary 
microglia and its potential role in processes involved in Alzheimer’s 
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disease. This study may help to understand the differential role of TDP-43 
in the cytoplasm and in the nucleus cytoplasm, as well as its potential 
impact on the acquired toxicity or loss of cell function that may be crucial 
in clarifying the pathogenesis of TDP-43 proteinopathy. 
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3. MATERIALS AND METHODS  
 Two broad different approaches depending of the goal have been used for 
this study.  We performed in vivo experiments to achieve the Aims 1, 2 and 3, 
related to the characterization of the anatomical neuronal circuits and their 
physiological implications and biochemical features.  Experiments to achieve Aim 4 
were performed in vitro, as an approach for complete this aim which could not be 
carried out using the whole animal. 
 
 
 3.1 IN VIVO PROCEDURES  
3.1.1 BIOLOGICAL MATERIAL USED FOR THE EXPERIMENTS 
 All animal procedures were performed in rodents and were approved by 
the Ethical Committee of the Autonomous University of Madrid in accordance with 
the European Community Council directive 2010/63/UE. Efforts were made to 
minimize animal suffering as well as to reduce the number of animals used. 
 Animals were kept in the veterinary office provided by the Autónoma 
University of Madrid at the Medical School (Manager in charged D. David Muñoz 
Valverde). Animals were placed in a 12 hours’ light/darkness cycle room with 
controlled temperature and water and food provided at libitum. Animals inhabit in 
cages in accordance to the dimensions needed for each species. Transgenic mice 
were kept in a separate room and in cages were air is purified by HEPA filters. 
Before any surgeries or manipulation animals shared cages by living in community 
with other rats or other mice in each case. After surgical procedures, animals were 
placed in individual cages and placed in a special post-surgery room. 
 Most experiments were performed both in rats and mice in order to assess 
if there were any differences in the projection pathways between the two species. 
Transgenic mice models were essential to investigate specific biochemical 
characteristics of the BF neurons and for studying the neuronal pathways in 
disease stages. 
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Different species of rodents of both sexes have been used as follows:  
a) Adult Sprague-Dawley rats weighting from 220-280g. This group of animals 
was used for characterizing the anatomical pathways linking the BF nuclei to 
different cortices as well as for optogenetic experiments (Aim 1 and 2). 
 
b) Control mice C57 from 3 months to 2 years of age range and weighting from 
25-40g. These animals were used for studying the anatomical pathways linking 
the BF nuclei and different cortices and for the study related to the 
identification and location of IGF1 receptor (Aims 1, 2 and 3). 
 
c) B6.Cg-Tg (Chat-COP4*H134R/EYFP,Slc18a3)5Gfng/J (B6.Cg Tg) transgenic mice 
labelled for cholinergic neurons. These animals were used for studying the 
anatomical pathways linking the BF nuclei to different cortices. They were also 
used for optogenetic experiments and for assessing the location and 
functionality of the cholinergic neuronal population (Aims 1 and 2). 
 
d) Transgenic mice modeling the Alzheimer disease, APP/PS1. These animals 
were used for studying the anatomical pathways linking the BF nuclei and 
different cortices (Aim 1).  
 
e) APP/PS1 transgenic mice with a double mutation (NIH, USA). These animals 
were used to study of the expression and location of IGF1 receptor (Aim 3). 
 
 
 
3.1.2 NEURONAL TRACERS AND INJECTING MATERIAL 
 Fluorescent neuronal tracers were chosen based on their excitation and 
emission spectra so we could combine them and still being able to differentiate 
between them in a same sample under fluorescence and confocal microscope 
(Table 3.1). We also selected the tracers that could be combined with 
inmunohistichemical methods. 
 In a first step, we tested different concentration and volume injections of 
tracers to standardize the optimal procedures. Moreover, we tested different 
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surgical approaches by using both, glass pipette injection (pressure and electrical) 
and Hamilton syringes injections using syringes of different volumes sizes. 
Concerning the neuronal tracers, we also tested their consistency and reliability by 
changing their injection sites to assess that we obtain the same results no matter 
which tracer was employed. Once we had established the parameters and 
materials that worked best for our proposal, we define the working protocol. 
Rather than pipettes, Hamilton syringes (1 µl volume size, gauge 32) were chosen 
as the best instrument for injections.  
 
The neuronal tracers selected were the following: 
a. Fluoro-Gold (FlGo: injection; Fluorochromes, Llc. Denver, USA) is a 
neuroanatomical fluorescent tracer that retrograde labels the neuronal cell 
bodies. It is visualized in yellow color under fluorescence and confocal 
microscope (Table 3.1) 
 
b. Fast Blue (FB: deposit; Polysciences, Inc. Warrington, PA) is employed as a 
retrograde neuronal tracer, labelling the somas of the neurons. It is 
visualized in blue color under fluorescence and confocal microscope (Table 
3.1).  
 
c. Cholera Toxin subunit B (TxCh) is a retrograde and anterograde tracer 
visualized after an immunocytochemical DAB reaction as a black color 
under light microscope. 
 
d. Biotinylated Dextran Amine (BDA) is an anterograde neuronal tracer 
visualized after an immunocytochemistry 3,3´-Diaminobenzidine (DAB) 
reaction as a dark brown color under light microscope. 
 
e. Adeno-associated viral vector AAV5-CaMKIIα::ChR2(H134R)-
eYFP.WPRE.hGH (Addgene26969P, Penn Vector Core, University of North 
Carolina) (AAV5-ChR2),  is employed as an anterograde neuronal tracer 
tagged with a yellow fluorescent protein (eYFP). This signal is converted to 
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a DAB immunocytochemistry-permanent reaction and observed as a dark 
brown color under light microscope. 
 
f. Sindbis virus is employed as an anterograde neuronal tracer. We used two 
different variations, one was JK57M Sindbis mutant that expresses 
mCherry, so we can visualize the labelled-neurons in red color under a 
fluorescent microscope; the second Sindbis virus we used was JK100L2M, 
this is the regular Sindbis virus which expresses eGFP, so labelled-neurons 
can be visualized in green color under a fluorescent microscope (Table 3.1). 
 
 
 Excitation max Emission max 
FlGo 350-385 nm 530-600 nm 
FB 365 nm 420 nm 
GFP 488 nm 510 nm 
mCherry 587 nm 610 nm 
Table 3.1: Spectra excitation/emission wavelength of the different neuronal tracers  
used. 
 
 
 
3.1.3 STEREOTAXIC COORDINATES FOR BF AND CEREBRAL CORTEX 
 Coordinates were calculated according to the Paxinos and Watson Atlas 
(2007) to target the structures of interest for each case. All injection sites 
coordinates were measured from Bregma and the bone surface was taken as zero 
for the dorso-ventral coordinate. All injection stereotaxic coordinates are indicated 
in the following table. 
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Stereotaxic 
coordenates 
Target 
structure 
Stereotaxic 
coordenates 
R
a
t 
AP: -2.3 mm 
L: 5.5 mm 
DV: 1 mm 
 
S1 
 AP: -1.70 mm 
L: 3 mm 
DV: 1.5 mm 
M
ice
 
AP: -5.8 mm 
L: 7.0 mm 
DV: 1 mm 
A1 
AP: -2.46 mm 
L: 4 mm 
DV: 2.2 mm 
AP: -6.3 mm 
L: 3.5 mm 
DV: 0.5 mm 
V1 
 
AP: 0.0 mm 
L: 1.5 mm 
DV: 7.5 mm 
VDB/HDB 
AP:  0.74 mm 
L: 0.2 mm 
DV: 5 mm 
AP: 0.24 mm 
L: 1.5 mm 
DV: 8.8 mm 
HDB 
AP: 0.14 mm 
L: 1.2 mm 
DV: 5.7 mm 
AP: -1.32 mm 
L: 2.8 mm 
DV: 7.2 mm 
B nucleus 
AP: -0.58 mm 
L: 2 mm 
DV: 4.2 mm 
AP: -3.24 mm 
L: 3 mm 
DV: 2 mm 
mPfC 
 
AP: 3.72 mm 
L: 3 mm 
DV: 2 mm 
M 
 
Table 3.2: Stereotaxic coordinates and target structures in rat and mice.  
AP: antero-posterior; L: lateral; DV: dorso-ventral. 
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3.1.4 SURGICAL PROCEDURES  
 All surgeries in rats and mice were performed using the same common 
procedures.  All injection sites were planed previously to the surgical procedure.   
 Animals were anesthetized with an intraperitoneal injection of a mixture of 
ketamine (70mg/kg) and xylazine (5mg/kg) in NaCl saline solution. When all 
reflexes were abolished, animals were shaved from the head and then immediately 
placed in the stereotaxic frame (David Kopf Instruments, Tujunga, California) using 
ear bars or check bars to keep the head fixed in the appropriated position. The 
excess hair from the head after shaving was removed and the skin was cut to 
expose the skull. We also administrate to the animals the analgesic Metacam 
(meloxicam 1 mg/Kg sc) before they were placed in the stereotaxic frame. In some 
cases animals were maintained with inhalation anesthetic isofluorane (0.5%, 
maintenance doses). In the cases were isofluorane could not be used due to the 
procedure, and  the animal displayed any reflex or movement, supplementary 
doses of ketamine (35 mg/Kg)  and xylacine (2.5 mg/Kg) intraperitoneally were 
given. The protocol used is described as follows: A point of origin “the zero” is 
established in the stereotaxic frame for the all three stereotaxic coordinates 
(antero-posterior, lateral and dorso-ventral). A Hamilton Syringe (1l volume size) 
is fixed to the stereotaxic tower and its tip is placed above Bregma in the skull of 
the animal that has been previously fixed to the stereotaxic frame.  Bregma was 
determined by using the tip of a Hamilton syringe fixed to a holder in the 
stereotaxic tower, and was used as the “zero” from where all coordinates were 
calculated (Figure 3.1). Once the desire stereotaxic coordinates were calculated for 
each target area, a small hole was drilled using a drill of appropriate diameter 
depending on the species. The dura mater was pierced by using a syringe tip in 
order to allow an easy penetration of the Hamilton syringe tip. After this, the 
Hamilton syringe is loaded with the fluorescent neuronal tracer or substrate used 
for each experiment. To confirm the syringe is fully loaded and functional, we 
ejected a small amount of the content before entering the brain to reach the dorso-
ventral coordinate previously established. When entering the brain, we allow for 
10 minutes for the tissue to stabilize around the Hamilton syringe tip. After the 
injection of 20 to 80 nl, depending of the experiment, we allowed the tracer to 
diffuse for another 10 minutes. After this time, the Hamilton syringe was removed 
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and its functionality was again tested as described above.  Afterwards, the incision 
was sutured and the animals were housed in the post-surgery room. Animals were 
treated with Dalsy oral administrated in drinking water (ibuprofen 20mg/cc; 15 mg/Kg 
diluted in drinking water) during 2-5 days post-surgery; additional doses of Metacam 
(1 mg/Kg sc) were also administered when necessary. It was important that the 
animal had a full and quick recovery period after the surgery for both, the animal 
wellbeing and for the appropriate transportation of the neuronal tracers.  
 
 
Figure 3.1:  Photographs of the surgical device in lateral (A) and posterior (B) views. 
 
 
 
3.1.5 EXPERIMENTAL INJECTIONS GROUPS IN RAT AND MICE 
  Animals were divided in four different experimental groups in order to 
achieve the Aims 1 and 2: Anatomical potential projecting pathways and 
biochemical features of BF neurons, listed in Section 2.  
a. Animals (rat and mice) injected in S1/A1 cortices: 
 Rat: Anatomical experiments were performed in 11 adult Sprague-Dawley 
rats (RA-1 to RA11). The anatomical neuronal projections from the BF nuclei to 
these sensory cortices were studied by injecting (FlGo) or depositing (FB) the 
Stereotaxic tower 
 
Holder and Hamilton syringe 
 
Stereotaxic frame 
 
Ear bars 
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neuroanatomical fluorescent retrograde tracers in the S1 and A1 cortices 
respectively. 
 After appropriate craniotomy, 40 nl of 4% saline solution of FlGo was 
injected in S1 cortex in the 11 rats using a 1l Hamilton syringe using the 
stereotaxic coordinates indicated above. Deposits of 2 mm2 of absorbable gelatin 
“Spongostan” embedded in 1% saline solution of FB were also placed for 20 
minutes in A1 using the stereotaxic coordinates specified in Table 3.2.   
 Mice: Anatomical experiments were performed in 18 B6.Cg-Tg transgenic 
mice. For a better understanding of the biochemical characteristics of the cortical 
afferent connections from the BF, FlGo injections in the S1 cortex and FB deposits 
in the A1 cortex of the animals were made. After appropriate craniotomy, 100 nl of 
a 4% saline dilution of FlGo was injected in S1 with a 10 µl Hamilton syringe using 
the stereotaxic coordinates specified in Table 3.2. Deposits of 0.5-1 mm2 pieces of 
absorbable gelatin “Spongostan” soaked in a 1% saline solution of FB were placed 
on the appropriate cortex in the animals, for 15 min. 
 
b. Animals (rat and mice) injected in S1/V1 a1: 
 Rat: Anatomical experiments were performed in 11 adult Sprague-Dawley 
rats (RA-12 to RA21). The anatomical neuronal projections from the BF nuclei to 
these sensory cortices were studied by injecting the fluorescent retrograde tracers 
FlGo and FB in the S1 and V1 cortices, respectively. After appropriate craniotomy, 
40 nl of 4% saline solution of FlGo was injected in the S1 cortex in 10 rats using a 
1l Hamilton syringe following the stereotaxic coordinates indicated above. 
Similarly, 40 nl of FB were injected in the A1 cortex following the stereotaxic 
coordinates listed in Table 3.2.  
 Mice: Anatomical experiments were performed in 15 B6.Cg-Tg transgenic 
mice. For a better understanding of the characteristics of the cortical afferent 
connections from BF, FlGo injections in the S1 cortex and FB deposits in the V1 
cortex were made. After appropriate craniotomy, 100 nl of a 4% saline dilution of 
FlGo was injected in the S1 cortex with a 10 µl Hamilton syringe at the specific 
stereotaxic coordinates (Table 3.2). Deposits of 0.5-1 mm2 pieces of absorbable 
gelatin “Spongostan” soaked in a 1% saline solution of FB were also placed on the 
V1 cortex for 15 min. 
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c. Animals (rat and mice) injected in basal forebrain structures: 
 For this set of experiments different anatomical tracing techniques were 
used.  
 
Since we were interested in the BF nuclei projections to specific targets and 
the possible reconstruction of neuronal networks with novel tracing techniques, I 
spent some time to Dr. Laszlo Zaborszky´s Laboratory in the Centre for Molecular 
and Behavioral Neuroscience at Rutgers University (New Jersey, USA). Here, we 
worked together to implement a technique to inject in the BF of rats and mice two 
modified Sindbis vector viruses (Cold Spring Harbor Laboratories) used for 
neuronal tracing: 1) A variant modified virus labelled with mCherry, and 2) A 
variant modified virus labelled with GFP. 
 
 Once back in Spain, fluorescent retrograde tracers (FlGo and FB) and 
another similar viral vector: adeno-associated viral vector AAV5-ChR2, were 
injected in the BF nuclei of rat. We chose this particular vector to drive the 
expression of the light-activated cation channel, channelrhodopsin-2, tagged with a 
fluorescent protein (ChR2-eYFP) that is specific to Ca2+/calmodulin-dependent 
protein kinase II α (CaMKIIα)-expressing neurons, ensuring that BF neurons 
anterogradely transport the virus to the cortex (Tye et al., 2011). 
Injections of the retrograde fluorescents tracers and the Sindbis virus were used 
for anatomical studies while injections of the AAV5-ChR2 were used for functional 
studies employing optogenetic techniques.   
 Rat: Anatomical experiments were performed in 8 Sprague-Dawley rats. To 
ascertain the presence of reciprocal connections between the HDB and B nucleus 
and the different cortices, two different approaches were used: 1) for anatomical 
studies 11 animals received 30 nl of FlGo in HDB as well as 30 nl of FB in the B 
nucleus (Table 3.2); 2) for physiological studies 15 Sprague-Dawley rats were 
injected with the adeno-associated viral vector AAV5-ChR2 into the HDB (n= 8) or 
the B nucleus (n= 7) using a 0.5 ml Hamilton syringe. Animals were allowed to 
recover for at least 3 weeks before optogenetic experiments were performed in 
order to allow the virus be transduced and transported to its target areas.  
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 Mice: 6 mice were injected with Sindbis virus (100 nl) using a glass pipettes 
attached to a picosplitzer device under a laminar flow chain in an isolated white 
surgical room. Also, 4 mice were injected with a 1µl Hamilton syringe 20nl of 
fluorescent retrograde tracers, FlGo and FB, in VDB/HDB and B. 
 
d. Animals (rats) injected in the prefrontal cortex: 
 In order to assess the implication of mPfC in the BF projecting pathways, 
injections of 30 nl of FlGo were performed in mPfC (Table 3.3) in 9 Sprague-Dawley 
rats. 
 
 Injection sites 
N
e
u
ro
n
a
l 
tr
a
ce
rs
 
 S1 A1 V1 mPfC VDB/HDB B 
FlGo 11 S-D 
18 C57 
  9 S-D 
 
11 S-D  
FB  11 S-D 
18 C57 
10 S-D 
15 C57 
  11 S-D 
AAV     8 S-D 7 S-D 
Sindbis 
mCherry 
    4 S-D 
4 mice 
 
Sindbis 
GFP 
     4 S-D 
4 mice 
Table 3.3: Summary of the animals injected with the different neuronal tracers in the 
distinct structures. S-D: Sprague-Dawley rats; C57: control mice; APP: APP/PSI transgenic 
mice. 
 
 
 
3.1.6 PHYSIOLOGICAL PROCEDURES. OPTOGENETIC STIMULATION 
(Aims 1 and 2: anatomical potential projecting pathways and biochemical features 
of BF neurons): 
 Optogenetic experiments were performed to study the possible functional 
implications of the neuronal circuits.  
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 Optogenetic technology takes advantage of genetically encoded light-
sensitive proteins, such as microbial opsins, that are introduced in intact living 
mammalian neurons, allowing manipulation of neuronal activity in vivo and in 
vitro (Boyden et al 2005; Deisseroth, 2010). The technique is characterized by the 
ability to modulate neuronal firing on a millisecond timescale with great cell-type 
specificity in awake, freely moving animals (Gradinaru et al 2007). A widly used 
depolarizing opsin is Channelrhodopsin-2 (ChR2; and genetically modified 
variants), a cation channel that induces action potential firing upon illumination 
with pulses of blue light (Mattis et al 2012) (Riga et al  2014). 
 
 
 Rat: We used 15 Sprague-Dawley rats injected with the viral vector for 
physiological experiments. 
 - Sensory stimulation: Whisker deflections were performed by brief air puffs 
using a pneumatic pressure pump (Picospritzer) that delivers an air pulse through 
a 1 mm inner diameter polyethylene tube (1-2 kg/cm2, 20 ms duration, resulting in 
whisker deflections of ≈15º). To avoid complex responses due to deflections of 
multiple whiskers, these were trimmed to 5 mm in length so that reproducible 
responses could be evoked. The experimental protocol consisted of pulses 
delivered to the principal whisker (whisker that gives the highest spike response) 
at 1 Hz. We applied 120 whisker stimuli (control period; 2 minutes). Similar pulses 
were applied after blue light stimulation of the BF during 4 minutes (240 stimuli).  
 
 - Optogenetic stimulation: rats were anesthetized with a mixture of 
ketamine (100 mg/kg) plus xylazine (3 mg/kg) and stereotaxically injected with 
the adeno-associated viral vector AAV5-ChR2 into the HDB or the B nucleus 
(coordinates indicated in table 3.1). We choose this particular vector to drive 
expression of the light-activated cation channel, channelrhodopsin-2, tagged with a 
fluorescent protein (ChR2-eYFP) that is specific to Ca2+/calmodulin-dependent 
protein kinase II α (CaMKIIα)-expressing neurons, ensuring that BF neurons 
anterogradely transport the virus to the cortex (Tye et al., 2011). The coordinates 
were the same as above. Animals were allowed to recover for at least 3 weeks 
before electrophysiology experiments were performed. Optical stimulation of 
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ChR2-expressing neurons was achieved with light-emitting diodes (LED; 473 nm; 
Thomas Recording, Germany) delivered from an optical fiber (core diameter 120 
μm) positioned directly above the HDB or B nucleus. The LED was triggered with a 
square-step voltage command. Stimulation was applied by a single long-lasting 
pulse (1 s). Illumination intensity was <30 mW/mm2 at the BF, which is below the 
damage threshold of ~100 mW/mm2 for blue light (Cardin et al., 2010). 
 
 To study the effect on cortical responses of optogenetic stimulation of BF 
neurons, young adult rats were anesthetized with urethane (1.5 g/kg, i/p). The 
depth of anesthesia was sufficient to eliminate pinch withdrawal, palpebral reflex 
and whisker movements and was assessed periodically during the experiment. 
Local anesthetic (Lidocaine 1%) was applied to all skin incisions and supplemental 
doses of urethane were given to maintain areflexia. Animals were placed in a Kopf 
stereotaxic device (David Kopf Instruments, Tujunga, CA) in which surgical 
procedures and recordings were performed. The body temperature was 
maintained at 37 °C. An incision was made exposing the skull and small holes were 
drilled in the bone over the barrel and prefrontal cortices (Table 3.2). Field 
potential recordings were made with tungsten macroelectrodes (<1 MΩ, World 
Precision Instruments, WPI, Sarasota, FL). Field potentials were filtered between 
0.3 -100 Hz, amplified and sampled at 500 Hz. Signals were fed into a personal 
computer with the temporal references of the stimuli for off-line analysis with 
Spike 2 software (Cambridge Electronic Design, Cambridge, UK).  
 
- Data analysis: The average of the cortical evoked potentials triggered by 
tactile stimuli were calculated every 1 minute (60 stimuli), using Spike 2 software. 
The area of the evoked potential was measured from the negative slope beginning 
with the first negative wave up to the same voltage level with a positive slope. The 
evoked potentials were recorded two minutes before blue light stimulation 
(control period) and four minutes after the light stimulation. 
Statistical analysis was performed using Graph Pad Prism 7 software (San Diego, 
CA, USA). Results are reported as means ± SEMs. Data were normally distributed, 
according to the Shapiro–Wilk normality test and analyzed using a Student’s 
paired t-test. Statistical significance was set at a 95% confidence level (two-tailed). 
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 Mice: We used C57 mice injected with AAV5 virus and transgenic mice 
expressing the light-activated cation channel, channelrhodopsin-2, tagged with a 
fluorescent protein (ChR2-YFP) under the control of the choline-acetyl transferase 
promoter (ChAT). B6.Cg-Tg (Chat-COP4*H134R/EYFP,Slc18a3)5Gfng/J mice; The 
Jackson Laboratory) were used for optogenetic stimulation of the BF. Young adult 
mice (3-6 months old) were anesthetized with urethane (1.5 g/kg, i/p). The depth 
of anesthesia was sufficient to eliminate pinch withdrawal, palpebral reflex and 
whisker movements and was assessed periodically during the experiment. A local 
anesthetic (Lidocaine 1%) was applied to all skin incisions and supplemental doses 
of urethane were given to maintain areflexia. Animals were placed in a Kopf 
stereotaxic device (David Kopf Instruments, Tujunga, CA) in which surgical 
procedures and recordings were performed. The body temperature was 
maintained at 37 °C. An incision was made exposing the skull and small holes were 
drilled in the bone over the barrel and auditory cortices (AP 1-3 mm, L 5-7 mm, DV 
0.2-1 mm, and AP -2.5 mm, L 4 mm, DV 2.5 mm from Bregma, respectively) as well 
as on the BF, HDB (AP 0.14 mm, L 2 mm, DV 4 mm) and B nucleus (AP -0.7, L 2, DV 
4). Single-unit recordings were performed with tungsten microelectrodes (2-5 MΩ, 
World Precision Instruments, WPI, Sarasota, FL) and the cortical field potential 
was recorded through tungsten macroelectrodes (<1 MΩ). Unit recordings in the 
BF were also performed by an optrode (see below). Unit firing was filtered (0.3-3 
kHz), amplified via an AC preamplifier (P15, Grass Instruments) and sampled at 10 
KHz while field potentials were filtered between 0.3 -100 Hz, amplified and 
sampled at 500 Hz. Signals were fed into a personal computer with the temporal 
references of the stimuli for off-line analysis with Spike 2 software (Cambridge 
Electronic Design, Cambridge, UK).  
 
 - Sensory stimulation: Whisker deflections were performed by brief air 
puffs using a pneumatic pressure pump (Picospritzer) that delivers an air pulse 
through a 1 mm inner diameter polyethylene tube (1-2 kg/cm2, 20 ms duration, 
resulting in whisker deflections of ≈15º). To avoid complex responses due to 
deflections of multiple whiskers, these were trimmed to 5 mm in length, so that 
reproducible responses were evoked. The experimental protocol consisted of 30 
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pulses delivered to the principal whisker (whisker that gives the highest spike 
response) at 0.5 Hz (control period). Whisker stimulation was also applied after 
blue light stimulation of the BF during 30 minutes. Auditory click stimulation was 
performed by application of a brief (1 ms duration) square voltage pulse to Sony 
earphones. The stimuli were presented at a rate of 0.5 Hz at the level 50 dB. 
Following the baseline recording, stimulation was also applied after blue light 
stimulation of the BF during 30 minutes. 
 - Optogenetic stimulation: Optical stimulation of ChR2-expressing neurons 
was achieved with light-emitting diodes (LED; 473 nm; Thomas Recording, 
Germany) delivered from an optical fiber (core diameter 120 μm) or through an 
optrode (microelectrode 1-2 M  + optical fiber) positioned directly above BF area. 
The LED was triggered with a square-step voltage command. Illumination intensity 
was <30 mW/mm2 at the BF, which is below the damage threshold of ~100 
mW/mm2 for blue light (Cardin et al., 2010). Stimulation was applied by 20 ms 
pulse trains of 473 nm light at 5 Hz or by a single long-lasting pulse (200 ms). The 
stimulation area was very restricted since total transmitted light power was 
reduced by 50%, after passing through 100 µm of neuronal tissue, and by 90% at 1 
mm (Aravanis et al., 2007). 
 
 - Data analysis: The somatosensory or auditory evoked potentials were 
calculated every 1 minute (30 stimuli). The amplitude of the evoked potential was 
measured from the baseline to the first negative peak. The mean tactile response 
was measured from the peristimulus time histogram (PSTH) as the number of 
spikes evoked in the 0-50 ms time window after the stimulus onset divided by the 
number of stimuli. Also, the power spectrum and wavelet transform were 
calculated from cortical field potentials. Statistical analyses were performed using 
GraphPad Prism 5 software (San Diego, CA, USA) and consisted of paired 
comparisons between the same cells before and after BF optogenetic stimulation. If 
the data were considered normally distributed, according to the Shapiro–Wilk 
normality test, we used parametric statistics. For two groups, we used the t test 
(paired). For multiple comparisons we used one-way ANOVA analysis of variance 
followed by Bonferroni post-hoc test. Data are presented as mean ± standard error 
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of the mean (SEM). The threshold level of significance was set at P < 0.05 (*) and P 
< 0.01 (**) are indicated in results. 
 
 
3.1.7 ANIMALS PERFUSION  
After a survival period of one week animals were anesthetized with an 
overdose of ketamine and xylacine and perfused transcardially. Animals devoted to 
optogenetic procedure were perfused at the end of the experiment. The perfusion 
system consisted of a peristaltic bomb (Masterflex L/S) with an adjustable speed 
flux, which distributes the perfusion liquids throw the arterial system of the 
animal. The animal was placed lying on its back and a longitudinal incision was 
made from the pre-sternum to the abdominal region; once the skin and muscles 
were opened, the ribs were cut at both sides of the sternum so we had full access to 
the heart. Once the heart was exposed, an incision was made in the left ventricle 
and the cannula fixed to the perfusion system, was immediately inserted into the 
left ventricle so the perfusion liquids start circulating through the arterial system 
of the animal. In the case of rat perfusion, the cannula stayed placed in the aorta 
clamp with a gastrointestinal tweezers. In the case of mice this was not needed. 
Then, we made an incision in the right auricle, so the lasting blood and perfusion 
liquids could exit by the return-broad-stream. The composition, volumes and order 
of the perfusion liquids were as follows: 
1º) 0.9% saline was perfused at low speed to clear out the blood of the 
circulatory system. 1 cc of heparin is added to the saline to help in the washing 
step. Saline is perfused until the liquid exiting the right auricle looked clear,  
meaning the circulatory systems must be clean at that point. The approximate 
volume used was 0.5 L for rat perfusion and 300 ml for mice. 
2º) A 4% paraformaldehyde fixative solution in phosphate buffer 0.1 M, pH 
7.4 (500 ml for rats and 200 ml for mice), was perfused over 50 minutes for rats 
and 30 minutes for mice. 
3º) Finally, increasing concentrations of sucrose in 0.1 M phosphate buffer 
were perfused. ( 0.5 liters in rats and 300 ml in mice 5% sucrose solution; 250 ml 
for rats and 150 ml for mice of 10% sucrose solution; 250 ml for rats and 100 ml 
for mice of 20% sucrose solution). 
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 Once the perfusion finished, the skull was opened and the brain was 
extracted. Brains were immersed in 4% PFA for 24 hours (post-fixation process) 
and stored in 30% sucrose for at least three days for tissue cryopreservation. The 
sucrose role in the cryopreservation process was to create an extracellular 
hyperosmotic medium that avoids the intracellular-microglass formation that may 
cause a potential damage to the cells when the tissue was frozen.  
 
 
3.1.8 TISSUE PROCESSING 
The brain tissue was fixed to the microtome plate using Tissue Teck, a 
special solution which acts as a glue. Brains were sectioned in a frozen microtome 
(Leica cryostat) at -15º C on the coronal plane at 40 m. 
 Sections were collected in three consecutive ordered series devoted to Nissl 
staining, fluorescent visualization and storage series. Series processed for Nissl 
staining were used for delimiting structures; fluorochrome series were devoted to 
the neuronal tracers labelled results and were studied both under a Nikon 
Axioskop fluorescent microscope and under a confocal microscope (Leica TSC SP5) 
using a Tile Scan tool of LAS AF software. Once sectioned, slices were mounted and 
process for histology. They were dehydrated in ethanol for 15 seconds’, followed 
by a six-increasing concentration of xylol solutions for a total of 30 minutes. Then 
the sections were covered using DePeX as mounting medium and they were 
allowed to dry at room temperature. Once the mounting media was dry, the slides 
were kept in the fridge to protect the fluorochromes integrity. The third series of 
sections were kept for further analysis and immunohistochemically techniques 
described in the next subsection 3.1.9. These sections were kept in the freezer in 
an anti-freezing solution at -20º C. 
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3.1.9 INMUNOHISTOCHEMICAL AND STAINNING TECHNIQUES  
 
a) Nissl staining:  
 
- Leave sections overnight in 70º ethanol for tissue dehydration and adipose 
 tissue removal. 
- 2 x rinsing in distillate water 
- Cresil violet stainning (5g cresil violet in 500 cc distillate wáter + 0,25 cc  
glacial acetic acid), 2 to 6 minutes in 45º C in a shaking bath 
- 2 short wash in distillate wáter to wash the excess of dye 
- 1 minute dehydratation in 70% etanol 
- 1 minute in 96% etanol to remove the lipids and the unspecific dye 
- 10 minutes in 100% clorophorm, shaking 
- Quick step in 96% etanol 
- Differentiation in acetic-ethanol (960 cc od 96% etanol + 17 cc of glacial acetic  
acid) 
- 1 minute dehydratation in 100% etanol 
- Dehydratation and rinsing in a 6 x 10 minutes’ steps in increasing 
concentration solutions of xylol 
- Mounting and covering with DePeX of the slides 
- Let dry at room temperature 
 
 
b) ChAT inmunohistochemistry:  
 
- Wash in 0.1 M Phosphate Buffer (PB) 4 x 10 minutes 
- Wash in saline phosphate buffer (PBS) 3 x 5 minutes 
- Prepare incubation medium: 
o 8000 l 0.5% Triton in PBS solution 
o 2000 l normal horse serum 
o 0.5 g bobine serum albumina (BSA) 
- Preincubation of the tissue in the medium: 2 hours, shaking 
- Primary antibody incubation, 36-48 hours, shaking, room temperature  
o Goat anti ChAt (1:150). Chemicon AB 144-P 
- Wash in PBS 0.1 M, 4 x 5 minutes, room temperatura 
- Secondary antibody incubation, 2 hours, shaking, on ice 
o Alexa Fluor 546 Donkey Anti-goat IgG (H+L) (1:200). Life 
technologies 
- Wash in PBS 2 x 5 minutes 
- Mounting slides and cover 
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c) Glucose oxidase inmunohistochemistry:  
 
- Rinsing in PB 0.1 M 2 x 5 minutes 
- Endogenous peroxidase inactivation, 20 minutes 
o PB 0.1 M + H2O2 2% 
- Rinse in PB 0.1 M, 5 x 3 minutes 
- ABC kit (1 drop reagent A + 1 drop reagent B in each 5 ml of PB) in PB  
0.1 M + Triton X-100 1%, 2 hours of incubation 
- Rinse in PB 0.1 M, 2 x 5 minutes 
- Rinse in Acetate buffer (TAS) 0.1 M pH 6, 3 x 3 minutes 
o For 200 ml of TAS 0.2 M preparation: 
 5.88 g 3-hydrato sodic acetate 
 2.5 ml H2O bi-distillate  
- Reaction development 
o Solution A 
 50 ml TAS 0.2 M pH 6 
 1.23 g nickel sulphate (Nickel (II) Sulphate 6-Hydrato®.  
PAnreac 131445.1209 
 0.2 g D-Glucose®. Panreac 131341. 1 kg 
 0.02 g amonium cloride®. Sigma A-4514. 100 g 
 Add 0.003 g Glucose oxidase (Sigma G-2133, 10.000 units) 
o Solution B 
 50 ml H2O bi-destillaste 
 0.03 d Diaminobenzidine (DAB). Sigma D5637 5 g 
Mix the solutions A and B and add the glucose oxidase in shaking 
conditions 
 just before developing the reaction.  
Allow the reaction to develop by visual control until desire dye of the 
tissue. 
- Rinse in TAS 0.1 M, 2 x 5 minutes 
- Rinse in PB 0.1 M, 2 x 5 minutes 
- Mount the slices and cover the slides 
 
 
d) FlGo immunohistochemistry 
 
- Wash in 0.1 M Phosphate Buffer (PB) 4 x 10 minutes 
- Wash in saline phosphate buffer (PBS) 3 x 5 minutesGoat 
- Prepare incubation medium: 
o 8000 l 0.5% Triton in PBS solution 
o 2000 l normal horse serum 
o 0.5 g bovine albumin serum (BSA) 
- Preincubation of the tissue in the medium: 2 hours, shaking 
- Primary antibody incubation, 36-48 hours, shaking, room temperatura  
o Rabbit Anti Fluorescent-Gold antibody (1:150). Millipore 
- Wash in PBS 0.1 M, 4 x 5 minutes, room temperature 
- Secondary antibody incubation, 2 hours, shaking, on ice 
o Alexa Fluor 488 Donkey Anti.Rabbit IgG (1:200). Life technologies 
- Wash in PBS 2 x 5 minutes 
- Mounting slides and cover 
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e) Cholera toxine inmunnohistochemistry:  
 
- Wash in 0.1 M Phosphate Buffer (PB) 4 x 10 minutes 
- Wash in saline phosphate buffer (PBS) 3 x 5 minutes 
- Prepare incubation medium: 
o  
o  
o 0.5 g bobine serum albumina 
- Preincubation of the tissue in the medium: 2 hours, shaking 
- Primary antibody incubation, 36-48 hours, shaking, room temperature 
o Goat anti-Cholera toxine antibody (1:200). List Biological 
Laboratories, INC. 
- Wash in PBS 0.1 M, 4 x 5 minutes, room temperatura 
- Secondary antibody incubation, 2 hours, shaking, on ice 
o Alexa Fluor 546 Donkey Anti-goat IgG (H+L) (1:100). Life 
technologies 
- Wash in PB 2 x 5 minutes 
- Mounting slides and cover 
 
 
f) GFP immunohistochemistry: 
 
- Wash in PB 0.1 M, 2 x 5 minutes 
- Peroxidase endogenous innactivation (2% H2O2), 10 minutes 
- Wash in PB 0.1 M, 3 x 10 minutes 
- Preincubation, 2 hours, room temperatura 
o Normal goat serum (NGS) 10% 
o Bovine serum albumina (BSA) 1% 
o Triton X-100 “% 
- Primary antibody incubation, overnight, room temperature 
o Normal goat serum 3% 
o BSA 1% 
o Triton X-100 1% 
o Rabbit anti GFP (1:500). Chemicon International 
- Wash in PB 0.1 M, 5 x 10 minutes 
- Secondary antibody incubation, 2 hours, room temperatura 
o NGS 3% 
o BSA 1% 
o Triton X-100 1% 
o Goat anti Rabbit IgG biotinylated (1:100). Chemicon International 
- Wash in PB 0.1 M, 3 x 10 minutes 
- Incubation ABC Elite 1:100 in PB 0.1 M + Triton X-100 1%, 1 hour 
- Wash in TAS, 3 x 5 minutes 
- DAB reaction: DAB 0,02% + H2O2 0.0001% in PB 0.1 M, pH 7.4 
Reaction time will vary from one immuno to another, visual control. 
- Wash in TAS 0.1 M, 2 x 5 minutes 
- Wash in PB 0.1 M, 2 x 5 minutes 
- Mounting slices, counterstain with tionine and dehydratation 
 
49 
 
 
g) IGF1 Immunohistoichemistry 
 
- Wash in PB 0.1 M, 3 x 5 minutes, shaking, room temperature 
- Preincubation / blocking step in PBTBSA, at least 15 minutes, shaking, 
at room temperature 
o PB 0.1 M 
o Triton X-100 1% 
o BSA 1% 
- Wash in PBTBSA, 3 x 5 minutes 
- Rabbit anti IGF1 incubation, 1 hour, room temperature or overnight at  
4º C, shaking (500 l /well) 
- Wash in PBTBSA, 3 x 5 minutes 
- Alexa Fluor 546 Donkey Anti-goat IgG (H+L) (1:100). Life technologies 
incubation (1:1000) in PBTBSA, 1 hour, room temperature, shaking or 
overnight at 4º C. 
- Wash in PB 0.1 M, 3 x 5 minutes 
- DAPI staining 
- Wash in PB 0.1 M, 2 x 5 minutes 
- Mount in Gerbatol 
 
 
 
Antibody Host species Reactivity Dilution Suplier 
Anti-ChaT Donkey Goat 1:150 Chemicon 
Alexa Fluor 546 Donkey Goat 1:200 
Life 
technologues 
Alexa Fluor 488 Donkey Rabbit 1:200 
Life 
technologies 
anti GFP Rabbit GFP 1:500 Chemicon 
Biotinylated anti Goat Rabbit Goat 1:100 Chemicon 
Anti Fluorescent-Gold Rabbit FlGo 1:150 Millipore 
Anti IGF1 Rabbit IGF1 1:200 Lifescience 
Anti-cholera toxin B 
subunit 
Goat 
Cholera toxin B 
subunit 
1:200 List Biological 
Elite ABC kit ------- ------- 
1 drop of each 
reagent/ 5 ml 
Vector 
Laboratories 
Table 3.4: Antibodies and reagents used for immunohistochemistry. 
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3.1.10 CONFOCAL STUDY 
 The study of the fluorochrome series was performed under the confocal 
microscope (Leica TCSSP5), using the LASAF software TileScan tool. Samples were 
analyzed using bio-mapping (maximal projections) under both lin405 mm UV and 
linAr488 mm using a 10x objective, for the quantification of neurons in each 
channel. Images are a stack of sections in maximal projection, but neurons were 
counted in each individual layer. Maximal projections of the images were analyzed 
in the two channels (UV and green) and the merged image was studied too. The 
procedure used was as follows: 1. For the neuronal counting each channel was 
selected in each section of the ROI (Region of Interest). We eliminated the 
nonspecific background, and convert the images to 8 bits; we then smoothed them 
out with the filter to apply the previous segmentation particle analyzer. In some 
cases it has been necessary to use the ROI from the BG subtraction plugin tool and 
the Watershed tool to separate and count particles correctly. In cases where the 
particle analyzer results were entirely satisfactory they were manually reviewed in 
the Cell Counter plugin. 2. To calculate the proportion of double labeled neurons, a 
manual multipoint tool was used on the merged image and separate channels were 
used as well to corroborate the results. In doubtful cases, a possible co-localization 
of channels was assessed in a merged image combining images of the resulting 
ROIs in the previous section, in both color channels. 
 
 
 
3.2 IN VITRO EXPERIMENTS 
 In this Section we explain the materials and methods for achieving our Aim 
4, which was to study the effect of TDP-43 knockout in BV2 cells and primary 
microglia and its potential role in processes involved in Alzheimer’s disease. 
 
3.2.1 BIOLOGICAL MATERIAL 
- TDP43 oligomers 
- Cellular cultures of BV2 cells  
- Cellular cultures of microglia 
- Transgenic model of Tardbp loxP/loxP mice 
51 
 
 
3.2.2 PROCEDURES  
3.2.2.1 Experiment 1 (in vitro): BV2 cells 
 For this experiment BV2 cells were used. BV2 cell is the immortalised 
murine microglial cells line that has been frequently used as a substitute for 
primary microglia (PM): 
o Step 1: Coating and seeding 
 We coated two 96 well plates with PDL 0.5ng/ml – one with coverslides and 
one without) per each student. In each well 2500 cells (32 wells for plate without 
coverslides and 24 with coverslides) were seeded in DMEM (Dulbecco's Modified 
Eagle's medium) with low glucose, 10% FCS (fetal calf serum) and without 
antibiotics and left in incubator on 37ºC. After 24 hours siRNA transfection was 
performed. siRNA protocol is shown below: 
 
siRNA transfection mix per well: 
- 50nM (1.75ul Optimem + 5.75ul siRNA) 
- Lipofectamine2000 (0.27ul Lipofect + 7.23ul Optimem) and wait 5 minutes 
- Mix and keep in the room temperature for 20 minutes 
- Add 15ul of siRNA transfection mix to each well and incubate on 37ºC  
- Change the medium the next day (about 14-16 hours, not toxic) to 
 remove Lipofectamine with DMEM low glucose, 10% FCS, 1%PS (fosfatidyl  
serine) 
- For siRNA transfection different oligomers were used – TDP pool, oligo1, 
 oligo2, oligo3, oligo4 (divied into two plates) and GC as a control in both 
 plates. In coverplates only TDP pool was used. 
 
  
 After 8 hours the medium was changed, either with full serum fresh 
medium (FED) or serum free (STARVED) in the plate and the coverslides. During 
the same day, HeLA SweAPP cells for Aβ production were seeded for uptake assay. 
Both BV2 plate/cover slides and HeLa SweAPP cells were left in the incubator on 
37 ◦C for 12-15 hours. The medium was replaced with the medium from HeLa 
SweAPP, which was already taken out and incubated for 4 hours before transfer 
the medium from BV2 plate. This medium was then collected for further analysis, 
and Alamar Blue Assay was done to access viability of the cells. BV2 plate was 
incubated on 37 ◦C for last 15 hours. Consequently, medium from BV2 plate was 
collected into the empty plate and preceded for clearance assessment by MSD 
(Meso Scale Discovery).  
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o Step 2: Bicinchoninic acid (BCA) assay and Western Blot (WB) 
 BCA is a kit for measuring the protein amount. It is necessary to avoid 
mistakes by loading different amount of protein. Colorimetric detection and 
quantitation of total protein was analyzed. This method combines the well-known 
reduction of Cu+2 to Cu+1 by protein in an alkaline medium (the biuret reaction) 
with the highly sensitive and selective colorimetric detection of the Cu+1 using a 
unique reagent containing bicinchoninic acid. The purple-colored reaction product 
of this assay is formed by the chelation of two molecules of BCA with one cuprous 
ion. (Figure 3.1). 
 
  Figure 3.2: BCA analysis Chemiluminiscence Fuji LAS 4000. 
 
Western Blot protocol 
- Sample preparation – loading amount based on BCA results 
- Electrophoresis – 200 V for 40 minutes 
- Transfer – 10 minutes  
- Labelling – 1◦ Ab 1:5000 Rb AntiTDP43 (rabbit) over night on 4 ◦C 
- 3 times wash with PBS-T 
 2◦ 1:10000 RbαTDP43 for 1 hour  on room temperature 
- 2 times wash with PBS-T and 1 time with PBS 
 
 
 
Internal loading controls:  
- β-actin 1:5000 (~37kDa)                            
- GAPDH 1:5000 (~45kDa)                        
- We incubated either GADPH or  β-actin with 1◦ Ab -AntiTDP43 (Rabbit) 1:100 
 (5ml 5% milk, 5ul TDP43 Ab, 1ul of β-actin/GAPDH) for 1 hour, room 
temperature. 
- 3 times wash with PBS-T 
- with 2◦ Ab –αRb 1:100 (5ml 5% milk, 5ul TDP43 Ab, 1ul of β-actin/GAPDH) 
 for 1 hour, room temperature. 
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o Step 3: MSD analysis 
 MSD is a unique technology that offers an ultra-low detection of biomarkers 
in single or multiple formats. The quantification of biomarkers is performed by 
electrochemical stimulation. We focused on detection of Aβ, APP using 96 well 4-
spot array to measure the clearence of these markers from the BV2 medium. 
 
o Step 4:  Alamar Blue Assay 
 Alamar Blue Assay is designed to measure quantitatively the proliferation of 
various human and animal cell lines, bacteria and fungi. Alamar Blue Assay 
incorporates an oxidation-reduction indicator that fluoresces based on metabolic 
activity and at the same time changes color in response to chemical reduction of 
growth medium resulting from cell growth. 
  
 Alamar Blue procedure:  
- Pipette 0.4 ml of Alamar Blue into a test tube.  
- Dilute to 10 mls with phosphate buffer.  
- Mix well.  
- Pipette 100 µl into each well. 
      
 
o Step 5: Confocal Microscopy 
 BV2 coverslides were used for phagocytic assay on BV2 cells. Fluorescently 
labelled Aβ in two time intervals (1 hour and 15 minutes) and lysotracker 561(75 
minutes) were applied for the phagocytic assay. Samples were analysed by 2-
photon confocal microscopy. 
 
 
3.2.2.2 Experiment 2 (ex vivo): Primary microglia  
o Step 1: Fagocitic assay 
Primary microglia preparation from pups P5 (litter 5) was obtained from 
Tardbp loxP/loxP mice, flanking exon 3. (Figure 3.3) 
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Primary Microglia Primary Cultures protocol: 
- Remove the brain, remove the meninges, dissect the cortex 
- Place in HBSS 4ºC 
- Cut the cortical tissues with scissors in small pieces 
- Place in 15ml tubes, containing 3 ml of TripleX, incubate 37ºC for 20 min 
- Resuspend with 5 ml pippete up-down 10 times 
- Dissociate mechanically the tissues re-suspending with 1 ml pippete slowly 
 10 times 
- Spin down the cells suspension at 400g for 4 min 
- Remove the supernatant and re-suspend in 10 ml of DMEM 4.5g glucose  
(without sodium pyruvate), 10% FCS, 1% PS 
- Count cells and plate 1x106 in T75 flask 
 
 
 
Primary Microglia Purification Protocol: 
- Changed to a fresh medium after 2-4 days. 
- Change the medium twice a week, exchanging about 50% of the medium. 
- After 2-3 weeks, microglia can be harvested by shaking (shake vigorously 
  the flask for at least 5-10 min and check at the microscope. 
 
 
 
Figure 3.3: Primary microglia culture and transgenic model of Tardbp loxP/loxP mice. 
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Once the primary microglia was purified, we seeded the microglia cells in a 
96 well plate, and after 3 days we started the fagocitic assay.  
We had two different situations: control and TAT-CRE (knockout). In each 
situation we had four conditions: different TDP43 agregates concentration (100nM 
and 500nM) and uptake time line (2 hours and 30 minutes).  
 
Preparation of dilutions: 
- Stock: 20uM; For 20.000 nM.  
- For TDP43 100nM dilution 1:200 (1ml: 5ul of oligo + 
 995ul of serum free médium).  
- For TDP43 500nM 1:40 (1ml: 25ul of oligos + 975 serum free medium) 
 
 
Our phagocitic assay on primary microglia (3 days post-treatment) was as 
folows: we coated two 96 well plates with astrocite medium where we have 
previosly placed  one coverslides per well. In line 1 (GC) and 3 (TDP43 knockout) 
we added a medium containing TDP43 agregates in a 100nM concentration, while 
in lines 2 and 4 we added on top of the cells  medium containing TDP43 agregates 
in 500nM concentration and we incubated them at 37ºC for different time points. 
We also had some wells with just medium inside (labelled X and Y in the plate 
photograph). Medium from line 1 and 2 was removed in two hours and medium in 
lines 3 and 4 was removed in 30 minutes. After this, the cells were fixed  with PFA 
4% during 20 minutes, followed by washes with PBS. After fixation we added DAPI 
tostain the cells nuclei. Then we mounted the coverslides in a slide for confocal 
microscope adquisition. We also collected the medium from the wells without cells 
(just medium) for further analysis (Figure 3.4).  
 
 
 
 
 
 
 
 
Figure 3.4: Fagocitic assay of TDP43 agregates in microglia cells. 
Control TAT-CRE Treatment Time 
O O O O 100 nM 2 hrs 
O O O O 500 nM 
O O O O 100 nM 30 min 
O O O O 500 nM 
O O O O For IF use 
O O O O 
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 We monitored the plates under optic microscope after 1.5 hours and 24 
hours and 3 days of treatment. We kept the cells to assess the possible uptake of 
the aggregates of TDP43 using immunofluorescent staining and we also collected 
the medium (Kept in -20ºC) for fractionation and Western Blot assays. 
 
 With these primary microglia cells in the cover-slides we performed 
immunofluorescence assay to detect the TDP43 aggregates uptake by the primary 
microglia cells.  
 Afterwards, we studied the mounted slides containing primary microglia 
under confocal microscope (Figure 3.6). 
 
Protocol for Immunofluorescence: 
- Fix in 4% PFA /10-15 min at room temperature 
- Wash in PBS 
- Block/permeabilize (10% Donkey Serum, 500ul + 0.1% TX100 /30 min 
 at room temperature) 
- 1º Antibody in blocking / 90 min at room temperature 
 
 12 wells: Ms α His 1:100  
    Rb α Iba1 1:500 
- Wash in PBS 
- 2º Antibody Alexa 1:1000; DAPI 1:10k / 45 min at room temperature 
- Wash well in PBS 
- Mount on slides in DAKO fluorescent mounting medium 
- Leave over night at 4ºC for the mounting medium to polymerize 
 
 
 
 
        
 
 
 
 
 
 
 
 
 
  Figure 3.5: Fagocitic Primary Microglia assay plate. 
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  Figure 3.6: Slide of primary microglia fagocitic assay. 
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APPENDIX: 
 
Phosphate buffer 0.1 M protocol: 
- 31.7 g phosphate di-hidrogen sodium 1-hidratated 
- 113 g di-sodium phosphate anhidro 
- Mix the previous substrates in 5 liters of distillated water 
- Adjust pH to 7.4 (with acetic acid or sodium hydroxide) 
- Add 0.2 M phosphate buffer and distillate water in the same proportion to  
obtain 0.1 M buffer. 
 
 
 
 
Fixative solution protocol: 
- Heat 0.5 liters of distillate water at 60º C 
- Filter 500 ml of 0.2 phosphate buffer 
- Add the 500 ml of phosphate buffer to the distillate water previously filtered 
- Add 40 g of paraformaldehyde (PFA) to the previous solutions. To help the 
 mixing add few drops of NaOH 
- Keep the solution in the fridge 
 
 
Anti-freezing solution for storage: 
- 100 cc phosphate buffer (33.65 g monobasic sodic phosphate + 7.7 g  
sodic dihidroxide, in 1 liter of distillate water) 
- 300 cc glycerin 
- 300 cc etilen-glycol 
- 300 cc distillate water 
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4. RESULTS 
 The results are organized in five Sections (4.1-4.5) in order to answer our 
Aims. The results corresponding with Aims 1 and 2 concerning the anatomical 
neuronal circuits linking the BF and the different cortices and the biochemical 
features of the neurons of these pathways are explained in sections 4.1, 4.2, 4.3 and 
4.4. The results concerning the location of the IGF1 receptors in control and 
APP/PS1 mice answering the Aim 3 are explained in the section 4.5. The Aim 4 
results concerning the possible role of TDP43 in AD are listed in section 4.6. 
 
 
4.1 BASAL FOREBRAIN-SENSORY CORTICES CONNECTION 
PATHWAYS  
Our first Aim, 1.1, was to delineate the potential specific neuronal groups in 
the BF involved in the control of specific sensory cortices. To achieve this Aim 1.1, 
retrograde tracers were injected or deposit in the sensory cortices of mice (S1 and 
A1 cortices) and rat (S1, A1 and V1 cortices). Also, our Aim 2, to analyze the 
biochemical features of the BF neurons that give rise to these pathways is 
presented in this Section. 
 
MICE: experiments were performed in C57 wild type mice to study the 
connections linking the different BF nuclei and the distinct sensory cortices (S1, 
A1).  
The anatomical study of the BF efferent connections to the S1 and A1 
cortices was performed on 18 cases. The locations of the FlGo injection site in the 
cortices as well as the FB deposit were confirmed using the sections devoted for 
fluorescence (Figure 4.1) and Nissl studies. Both injections and deposits were 
confined to the desired site without signals of diffusion in any case.  
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Figure 4.1: Location of the injection and deposit of fluorescent retrograde tracers. 
Microphotographs of coronal brain sections and schematic drawings showing the injection sites of 
the retrograde tracers in a representative animal. A: FlGo injection in S1 cortex; B: FB, deposit in the 
A1 cortex;. Calibration toolbar 600 µm. 
 
 
 In all 18 cases, the study of the fluorescence series allowed us to detect 
numerous fluorescent retrograde single- or double-labeled neurons in the HDB, 
VDB (Figure 4.2) or in the SI and B nuclei (Figure 4.3). 
 
Neurons in the SI and B nuclei were considered together because the two 
nuclei were difficult to delineate at caudal levels. Two different tracers (FlGo and 
FB) were injected/deposited in the two different sensory cortices (S1/A1 
respectively) of the same hemisphere (n=10 mice). This experimental approach 
allowed us to establish whether the pathway of the BF cortical projecting neurons 
reaches A1, S1 or both cortices and if so in which proportion. The microscopy 
study of VDB/HDB nuclei revealed numerous intermingled neurons in these nuclei 
labeled by FlGo, FB or both tracers (Figure 4.2).  
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Figure 4.2: Distribution of labeled neurons in VDB/HDB 
A-C: confocal microscope image of retrograde labeled neurons in VDB/ HDB; D, E: 
fluorescence microscope image of both FlGo and FB labeled neurons in the VDB and HDB. 
Dash line indicates the medial hemispheric line; F: Image combining fluorescent microscopy 
with ChAT immunocitochemistry techniques in HDB. Asterisk point to cholinergic neurons. 
Calibration toolbar 250 µm. 
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Figure 4.3: Distribution of labeled neurons in VDB/HDB. 
A-F: Samples of fluorescent microscope images of single and double labeled neurons in 
HDB. G, H: Samples of fluorescent microscope images of single and double labeled neurons 
in SI/B nucleus. Red asterisks point double labeled neurons. Calibration toolbars: C, D, F-
H: 230 µm, E: 530 µm.  
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Figure 4.4: Distribution of labeled neurons in B nucleus. 
A, B: Microphotographs of coronal sections showing retrogradely labeled neurons located in B 
nucleus of animals MCA-6 (top) and animal MCA-15 (bottom). Dash lines delimitate the B nucleus 
(B). C-G Confocal microscope detail of FlGo and FB labeled neurons in B nucleus. Calibration 
toolbar 280 µm. 
 
 
The study of the distribution and percentages of these neurons showed that 
34 ± 7.4 % of the neurons located in the VDB/HDB were labeled by both 
fluorescent tracers (neurons projecting to both the S1 and A1 cortices), while most 
of the VDB/HDB neurons (44.2 ± 7.4%) were single-labeled by FlGo injected into 
S1 cortex; only 21.8% of neurons were labeled by FB injected into A1 cortex. 
Conversely, the percentage of double-labeled neurons in B nucleus was lower than 
in VDB/HDB (22%)( Figures 4.2, 4.3 and 4.5), while the percentage of B neurons 
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single-labeled by either one or another tracer was roughly the same (40.6% from 
S1 and 37.4% from A1; Figures 4.4, C-H and 4.5). In addition, the immunochemical 
study revealed that fluorescent labeled neurons appeared to be scattered among 
the characteristic cholinergic neurons of the different BF nuclei and some of them 
were also positive for ChAT immunocytochemistry (Figure 4.2 F and 4.6). These 
percentage results have been normalized with the total number of labelled 
neurons in each region of interest (Figure 4.5). 
 
 
 
 
 
 
 
 
 
 
Figure 4.5: Graphic representation of number of labeled neurons in VDB/HDB and B 
nucleus after injection/deposit in S1, A1 or both cortices.  
 
 
 
 Figure 4.6: Microphotograps of ChAT inmmunostainning.  
White squares indicates ChAT-possitive neurons in HDB. Toolbar 250 µm. 
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  Our Aim 1.2 was to determine the existence and characteristic features of 
the neural networks linking different sensory cortices with the BF nuclei. Since we 
observed these preferential projecting pathways depending on the BF nuclei of 
study, we then wonder if these connections of the BF nuclei with the different 
sensory cortices were unidirectional or reciprocal. To achieve this purpose, we 
injected two retrograde tracers (FlGo and FB) at two different rostro-caudal levels 
of the BF, VDB/HDB and in B nucleus. We observed labelled neurons in the sensory 
cortices S1 and A1 confirming the reciprocity of these cortices with the BF. 
 
Figure 4.7: Labelled neurons in sensory cortex. 
Left: labelled neurons in S1 cortex; Right: labelled neurons in A1 cortex. Both 
injections of the tracer were in B nucleus.  
 
 
To elucidate if these anatomical results have a physiological correlation we 
asses these projecting pathways linking sensory cortices with the different BF 
nuclei by using a transgenic mice model B6.Cg-Tg (Chat-
COP4*H134R/EYFP,Slc18a3)5Gfng/J which has its chanelrhodopsin channels 
conjugated with a GFP protein so when stimulating optogenetically we are just 
exciting the cholinergic neurons. 
Since the above results indicate that neurons in HDB mainly projected to the 
S1 whereas B neurons similarly projected to the S1 and A1 cortices. We used 
optogenetic methods for selective stimulation of cholinergic neurons in specific BF 
areas. To verify that blue LED stimuli induced spike firing of cholinergic neurons, 
we used an optrode to perform unit recordings in the BF simultaneously with 
optical stimulation in the same place. Short-lasting blue LED stimuli applied to the 
BF (HDB or B nucleus) induced spike firing in the BF neurons of ChAT-ChR2-YFP 
mice with a mean latency of 6.2 ± 1.1 ms (Figure 4.9). All light-responsive cells (n = 
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12 cells) had slow spontaneous firing rates (0.5 ± 0.3 spikes/s). Also, a train of 
stimuli (20 ms pulse duration; 5 Hz) or a single pulse lasting 200 ms induced spike 
firing of BF neurons and a desynchronization of the cortical field potential (Figure 
4.9). During control conditions, the cortical field potential produced spontaneous 
slow oscillations reflecting a synchronized state induced by the anesthetic, which 
was reduced by blue light stimulation. Wavelet analysis showed that light 
stimulation induced an increase of fast cortical activity (>4Hz; Figure 4.8). The 
desynchronization in response to light stimulation lasted for only a few seconds, 
and could be evoked repeatedly. 
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Figure 4.8: Blue light stimulation of BF neurons induces spike firing in the BF and 
desynchronization of the somatosensory and auditory field potentials. 
A: a short-lasting blue LED stimuli induced spike firing in a representative B neuron (three 
superimposed traces are shown). B: a train of stimuli (20 ms pulse duration, 5 Hz) evoked 
spike firing increase in a HDB neuron and desynchronization of cortical field potentials 
simultaneously. The effect lasted less than 10 s. C: wavelet analysis of the same trace that 
in B showed a fast activity increase of cortical field potentials after the blue light 
stimulation. 
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To quantify desynchronization, we compared the power spectra of the 
cortical field potential before (30 s; control) and after the onset of blue light 
stimulation (a single pulse of 200 ms duration; 30 s). Figure 6 shows the 
percentage change with respect to the control values (100%) in the delta 
frequency band (0.5-4 Hz), in the theta frequency band (4- 10 Hz) and in a faster 
frequency band (10-30 Hz) that mainly correspond to beta frequencies. Data were 
calculated from 6 recordings in the S1 cortex and from 6 recordings in the A1 
cortex). Blue light stimulation to the HDB reduced delta activity in the S1 and A1 
cortices and increased theta frequencies and faster activities in the S1 and A1 
cortices (Figure 4.9). The same result occurred when the blue light was applied to 
the B area (Figure 4.10). Although the differences were not statistically significant, 
HDB stimulation increased more theta frequencies in the S1 and A1 cortices than B 
stimulation. By contrast, B stimulation increased more beta frequencies in both 
cortices than HDB stimulation (Figures 4.10 and 4.11). 
Blue light stimulation at the BF also increased the evoked potential amplitude 
elicited by whisker stimulation (somatosensory evoked potential) or by the 
application of clicks (auditory evoked potential). HDB optogenetic stimulation 
induced a long-lasting increase in either the somatosensory or auditory evoked 
potentials (Figure 4.9). The effect lasted at least 30 min and was larger for the 
somatosensory evoked potentials than the auditory evoked potentials (Figure 4.9). 
The mean amplitude increased rapidly from 6.6 ± 1.3 V in the control conditions 
to 11.4 ± 2.0 V, 5 min after optogenetic stimulation (ANOVA analysis, P = 0.002; n 
= 12) and remained 10.5 ± 1.9 V, 30 min after stimulation (ANOVA analysis, P = 
0.0016; n = 12; Figure 7C). Auditory evoked potentials were less affected by the 
blue light when it was directed at the HDB. The mean amplitude changed from 3.9 
± 0.6 V in the control to 4.8 ± 1.1 V 5 min after optogenetic stimulation (ANOVA 
analysis, P = 0.101; n = 12). The increase reached statistical significance 10 min 
after blue light stimulation (6.0 ± 1.6 V; ANOVA analysis, P = 0.0109; n = 12) and 
remained facilitated 30 min after stimulation (5.2 ± 0.8 V; ANOVA analysis, P = 
0.0207; n = 12; Figure 4.9). 
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Figure 4.9: Blue light stimulation of HDB nucleus induces an increase of 
somatosensory and auditory evoked potentials.  
A, raw data shows an important increase of the S1 evoked potentials (S1EP) and a modest 
increase of the A1 evoked potentials (A1EP) (control and 5 min. after blue light 
stimulation). B, the plot shows the time course in 12 cases. Note the larger increase in 
S1EP than in A1EP. C, plot of the mean amplitude measured in control and 5 or 30 min. 
after blue light stimulation at HDB nucleus. The amplitude increase was larger for S1 than 
A1 evoked potentials.  
 
 
In contrast to the HDB stimulation, B optogenetic stimulation induced a 
lower increase of somatosensory evoked potentials at 5 min after the application 
of blue light in comparison with HDB stimulation (Figure 4.10). The mean 
amplitude of the somatosensory evoked potential increased from 5.5 ± 0.5 V in 
the control conditions to 8.6 ± 0.9 V, 5 min after optogenetic stimulation (ANOVA 
analysis, P = 0.0217; n= 12) and 7.9 ± 1.0 V, at 30 min after stimulation (ANOVA 
analysis, P = 0.072; n= 12; Figure 8C). Auditory evoked potentials were also less 
affected by the blue light in comparison with the effect on the somatosensory 
evoked potentials. The mean amplitude changed from 3.7 ± 1.0 V in the control to 
4.4 ± 1.2 V, 5 min after blue light stimulation (ANOVA analysis, P = 0.1338; n= 
12), reaching statistical significance 10 min after blue light stimulation (5.2 ± 1.4 
V; ANOVA analysis, P = 0.0109; n = 12). However, the stimulation effect vanished 
30 min after optogenetic stimulation (4.2 ± 1.2 V; ANOVA analysis, P = 0.072; n= 
12; Figure 4.10). 
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Figure 4.10: Blue light stimulation of B nucleus induces an increase of 
somatosensory11and auditory evoked potentials. 
A, raw data shows that only somatosensory evoked potentials were affected by blue light 
stimulation at B nucleus (control and 5 min. after stimulation). B, the plot shows the time 
course in 12 cases. C, plot of the mean amplitude measured in control and 5 or 30 min. 
after blue light stimulation at B nucleus. The effect observed was smaller than in HDB 
stimulation. 
 
Once we observed that different neuronal groups in the BF of mice display 
specific anatomical pathways to sensory cortices, we would like to study if these 
neuronal pathways linking sensory cortices with different BF nuclei were 
equivalent and conserved in rats. 
RATS: Therefore, in order to detect the presence and characteristics of the 
pathways linking different sensory cortices with specific regions of the basal 
forebrain, simultaneous injections of FlGo and FB deposits were done in 21 
animals; 11 animals received a FlGo injection in S1 and FB deposits in A1 (Figure 
4.11) while in the remaining 10 animals FlGo and FB were respectively delivered 
in S1 and in V1 (Figure 4.11). In all cases, the FlGo injections were confined to the 
S1 layers and the FB deposits to A1 or V1. 
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Figure 4.11: Injections/deposits  of tracers in S1, A1 and V1 cortices of rats. 
Schematic drawings and microphotographs of brain coronal sections showing the FlGo 
injection sites in the S1 cortex (A) and FB deposits in A1 (B) and V1 (C) cortices. 
 
 
Neurons with retrograde labeling by FlGo, FB or both tracers were 
found in different BF regions in the 11 animals treated in the S1/A1 
cortices. FlGo labeled-neurons were located in both VDB and HDB, in the SI, 
and at all rostro-caudal levels of the B nucleus including, at the most caudal 
levels, the zona incerta (ZI) (Figure 4.12). However, neurons showing FB 
fluorescence were found in neither the VDB nor the HDB although they 
were present at all levels of the B nucleus as well as in the ZI and SI. Double-
labeled-neurons were found in both the B nucleus and ZI (Figure 4.12).  
Quantification of these neurons allowed us to establish that more 
than 98% of the HDB neurons were FlGo single-labeled while the rest were 
double-labeled; in the B nucleus 50% of the neurons were single-labeled 
with FlGo, 15% single-labeled with FB and 35% double-labeled (Figure 
4.14). 
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In the 10 animals with injection/deposits in the S1 (FlGo) and in V1 (FB) 
cortices, single FlGo, single FB and double-labeled neurons were found in HDB as 
well as at all levels of the B nucleus and in the ZI and SI. (Figure 4.13). Quantitative 
studies of labeling in the HDB showed 67.5% of neurons to be single-labeled with 
FlGo, 11% single-labeled with FB and 21.5% of the neurons to be double-labeled. 
In the B nucleus, 47.5% of the neurons were labeled with FlGo, 8% with FB and the 
44.5% remaining of the neurons were double-labeled. The percentages of this 
quantitative analysis have been normalized since the relative number of neurons 
was higher in S1 / V1 injected animals (Figure 4.14). All together these data 
confirmed that BF project to the cortex heterogeneously. 
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Figure 4.12: BF neurons projecting to S1, A1 cortices in the rat. 
Rostral to caudal schematic drawing of brain coronal sections where the locations of 
single-FlGo (orange, injection in S1), single-FB (blue; injection in A1) and double-labeled 
neurons (green) were located. 
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Figure 4.13: BF neurons projecting to S1, V1 cortices in the rat. 
Rostral to caudal schematic drawing of brain coronal sections where the locations of 
single-FlGo (orange, injection in S1), single-FB (blue; injection in V1) and double-labeled 
neurons (green) were located. 
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Figure 4.14: Normalized percentages of labelled neurons. 
A. FlGo single labelled neurons (orange), FB single labelled neurons (blue) and double 
labelled neurons (green) in HDB. B. FlGo single labelled neurons (orange), FB single 
labelled neurons (blue) and double labelled neurons (green) in B nucleus. 
 
 
 Once we have the anatomical results, we would like to assess, as in the case 
of mice experiments, if these anatomical projecting pathways have a functional 
correlation. For that purpose, we used optogenetic methods for selective 
stimulation of virus-injected neurons in specific BF areas (Figure 4.15). The mean 
area of the earlier negative wave was calculated every 60 stimuli and the mean 
area of the control period were considered as 100 %. HDB optogenetic stimulation 
induced an increase of the sensory evoked potential (SEP) in S1 cortex (Fig. 4.16). 
The mean area increased rapidly reaching a maximum 2 minutes after blue light 
stimulation (172±25%, P = 0.018; n = 8) that was sustained until 4 minutes after 
stimulation (155±27%; P = 0.042; n = 8). In contrast, SEP potentials were inhibited 
in the mPfC by blue light stimulation when this was directed toward the HDB. The 
mean area decreased slowly, the decrease reaching statistical significance 3 
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minutes after blue light stimulation (78±8%, P= 0.004 and 83±9%, P<0.001, 
respectively; n=8; Figure 4.16). 
 
Figure 4.15: Virus injection in HDB. 
A. Eschematic drawing of AVV5 virus injection site at HDB, Bregma 0.24mm. B. 
Microphotographs of AVV5 virus injection in the mice HDB. 
 
77 
 
B nucleus optogenetic stimulation induced a lower SEP increase, 
reaching statistical significance at 3 and 4 minutes after blue light 
stimulation (121±9%, P= 0.031 and 111±5%, P=0.048, respectively; n=10; 
Figure 4.16). B nucleus optogenetic stimulation also inhibited SEP in the 
mPfC (81±5%, P< 0.001; n=10)(Figure 4.16). However, the stimulation 
effect vanished 2 minutes after optogenetic stimulation. In summary, data 
indicate that BF stimulation also has heterogeneous effects on the cortex 
according to the stimulation location, supporting the above anatomical data.    
 
 
 
 
Figure 4.16: Optogenetic stimulation of BF induced cholinergic modulation of 
whisker responses in S1 and mPfC cortices.  
A: plot of SEP responses in controls (2 minutes) and during the 4 minutes after HDB blue 
light stimulation (1 s pulse duration). Note that HDB stimulation induced different 
simultaneous responses in S1 and mPfC cortices.  B: plot of SEP responses in control (2 
minutes) and during the 4 minutes after blue light stimulation (1 s pulse duration) in the 
B nucleus. Note that B stimulation induced different responses in the S1 and mPfC 
cortices. The light induced inhibition in mPfC lasted less than when the light was applied 
to the HDB. In A and B the mean of the two control values was considered as 100%. *, 
p<0.05; **, p<0.001. 
78 
 
Once we observed this specificity in the projecting pathways concerning the 
sensory cortices and the BF, we then wanted to know if this differential and 
specific projecting manner from sensory cortex to VDB/HDB and B also was 
present in the BF nuclei concerning other modality cortices. This was our Aim 1.3: 
to investigate the involvement of motor and prefrontal cortices in these networks, 
which results are explained in the next Section 4.2. 
 
 
 
 
4.2 BASAL FOREBRAIN CONNECTION PATHWAYS WITH OTHER 
CORTICES  
RAT: Fluorescent retrograde tracers were injected in BF nuclei of 11 rats to 
study cortical projections to the BF. The locations of FlGo and FB deposits in 
animals injected in HDB and B nucleus, respectively, were confined to the 
corresponding structures as shown in Figure 4.17.  
 
 
Figure 4.17: Fluorescent tracer injections in BF nuclei. 
Micrographs of injection sites and squematic drawing of FB injection in B nucleus and FlGo 
injection inHDB. 
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Injections resulted in single FlGo retrograde labeled-neurons in the 
prelimbic/infralimbic, cingulate and motor cortices, while single FB 
retrograde-labeled neurons only appeared in the cingulate and motor 
cortices (Figure 4.18). Most of the neurons in the motor cortex were FB 
single-labeled although a few were FlGo single-labeled, indicating that 
motor cortex mainly projects to the B nucleus; practically all the neurons 
detected in prelimbic/infralimbic cortex were FlGo single-labeled, 
indicating that prelimbic/infralimbic cortex projects to the HDB. Only a few 
double-labeled neurons appeared and they were confined to motor cortex. 
 
Figure 4.18: Labelled neurons projecting to BF nuclei. 
Schematic drawing labelled neurons projecting HDB (orange dots) and B nucleus (blue 
dots). 
 
 
 
To study if these circuits were reciprocal, we also injected in other 
animals the retrograde tracer FlGo in mPfC (Figure 4.19). Injections of the 
FlGo retrograde tracer in mPfC resulted in a great amount of neurons in all 
rostro-caudal levels of HDB (Figure 4.19) while a few neurons were located 
in B nucleus. 
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Figure 4.19: Injection in mPfC. 
A. Schematic drawing of FlGo injection in mPfC. B. Microphotographs of labelled neurons 
in HDB. 
 
 
 
 
4.3 CONTRALATERAL BASAL FOREBRAIN CONNECTIONS 
 
MICE: The anatomical pathways linking BF with cortical areas with the BF 
were studied by injecting or depositing the neuroanatomical fluorescent 
retrograde tracers FlGo and FB in 18 B6.Cg-Tg (Chat-
COP4*H134R/EYFP,Slc18a3)5Gfng/J mice. 
For a better understanding of the characteristics of the cortical afferent 
connections from BF, animals were divided into four groups of experimental 
procedures according to the injection side and the combination of both 
fluorochromes in the cortices. Group 2: FlGo injection in S1 of left hemisphere and 
FB deposit in S1 right hemisphere; Group 3: FlGo injection in A1 left hemisphere 
and FB deposit in A1 right hemisphere and Group 4: FlGo injection in V1 left 
hemisphere and FB deposit in V1 right hemisphere.  
 
The distribution and relative percentage of these neurons was different 
depending of the experimental group, as described below. 
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In order to corroborate whether one given sensory cortex (somatosensory, 
auditory or visual) received projections from the ipsi- and/or contralateral BF, 
experimental Groups 2 (n = 3), Group 3 (n = 3) and Group 4 (n = 2) received a FlGo 
injection in the left hemisphere in the SI, A1 or V1cortex respectively, and a FB 
deposit in the right hemisphere of same cortices. Group 2 received the 
injection/deposit in S1 cortices of both hemispheres. Single labeled neurons were 
also found in the contralateral BF; these neurons were present in VDB, HDB and SI 
but not in B nucleus (<2%). A rostro-caudal gradient that differed in the number of 
contralateral neurons in VDB and HDB was observed; from rostral to caudal in 
VDB the gradient increased from 15.7% to 27.2%, while in HDB the gradient 
decreased from 11.3% to 5.6% Figure 4.20 A-C).  
 
Group 3 received FlGo injection/FB deposit in A1 cortices of both 
hemispheres. In spite of the ipsilateral single labeled neurons found in VDB, HDB, B 
and SI nuclei, labeled neurons were also found in the contralateral BF (Figure 4.20 
D-F). In VDB 24.5% of the contralateral labeled neurons were observed at rostral 
levels and 19.4% at caudal levels. In HDB, 30% of total labeled neurons were found 
in the contralateral side. In this case, differences were not observed in the rostro-
caudal levels. In contralateral B nucleus, less than 2% of the total labeled neurons 
were observed.  
 
Group 4 received the injection/deposit in V1 cortices of both hemispheres. 
Ipsilateral single labeled neurons were found in VDB, HDB, B and SI nuclei. Single 
labeled neurons were also found in contralateral BF (Fig. 4.20 G-I). In contralateral 
VDB 15.8% of labeled neurons were found at the rostral levels while 27.2% of 
labeled neurons were observed at the caudal levels. In HDB a rostro-caudal 
decreasing gradient was observed in the percentage of contralateral labeled 
neurons that ran from 15.7% to 3.8% respectively. In B no contralateral labeled 
neurons were observed. In B/SI nuclei less than 2% of labeled neurons were 
contralateral. 
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Figure 4.20: Fluorescent microscope images showing the rostro-caudal distribution 
of fluorescent labeled neurons. 
A-C: Fluorescent microscope images from animals of group 2 (FlGo injection an FB deposit 
in S1); D-F: Fluorescent microscope images from animal of group 3 (FlGo injection and FB 
deposit in A1); G-I: Fluorescent microscope images from animal of group 4 (FlGo injection 
and FB deposit in V1). J-L: Graphic representation of rostro-caudal distribution of neurons 
in VDB, HDB and B nucleus in group 2 (J), group 3 (K) and group 4 (L). Calibration toolbar 
600 µm.  
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Figure 4.21: Schematic summary drawings of the projections from the BF to the 
sensory cortices and reciprocally in the different neuronal tracers injected groups. 
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4.4 BF-CORTICAL CIRCUITS IN APP/PS1 TRANSGENIC MICE 
To achieve our Aim 1.4 in which we wanted to compare the projection 
pathways of these BF-cortical networks in control (above results) and APP/PS1 
mice to study if the connections described in the above Sections display any 
changes in the AD model.  
6 mice of 9 to 14 months of age were injected in the sensory cortices (A1 
and V1) with retrograde tracers, FlGo and FB respectively. Fewer neurons seems 
to be projecting to S1 cortex from HDB comparing APP with control mice. 
However, further analysis should be done to establish the relevance and 
percentages of that suggested decrease in number. 
We did also a ChAT immunohistochemistry to study if that decreased in 
neurons affected to the cholinergic ones. We observed a decrease in the number of 
cholinergic neurons in B nucleus both in males and females in APP/PS1 mice 
compared with controls. Moreover, in APP/PS1 females, the number of cholinergic 
neurons in HDB seems to be reduced compared with controls and APP male’s mice 
(Figure 4.22). 
 
Figure 4.22: Cholinergic neuronal loss in APP/PS1 mice compared with 
 controls. 
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Due to results shown in Section 4.4, we started the study of the 
possible toxicity leading to a lost in the neuronal function in AD mice 
models. This study was performed using two different approaches. The first 
one was englobes Aim 3, the study the location OF IGF1 receptors in the BF 
nuclei in control and APP/PS1 transgenic mice (Section 4.5). Our second 
toxicity approach, related with Aim 4, was the in vitro study in BB2 cells and 
microglia cultures (Section 4.6). 
  
 
 
 
 
4.5 IGF-1 RECEPTOR LOCATION IN CONTROL AND APP/PS1 MICE 
In this Section, we explain the results related with our Aim 3 
where we wanted to identify the location of IGF-1 receptors in the BF 
nuclei of C57 control and of APP/PS1 Alzheimer mice model to investigate 
its possible implication in the pathogenesis of AD. 
 
For these experiments, 6 C57 mice aging 9 to 12 months and 4 
APP/PS1 mice of the same age were perfused and brains were sectioned for 
immunohistochemistry analysis for ChAT and IGF1 receptor. All brains 
sections were processed but we focused our study on the VDB/HDB and B 
nucleus containing-sections. 
 
First of all we performed an experiment to establish if there was co-
localization of Ach and IGF1 receptor in the BF neurons. We found positive 
double labelled neurons for ChaT and IFG1 both in the HDB and B nucleus 
(Figure 4.23) 
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Figure 4.23: Co-localization of possitive neurons for ChaT and IGF1 in BF neurons 
 
 
Once we have a positive co-localization of ChAT and IGF1 we did the same 
inmmunohistochemistry for comparing control and APP/PS1 mice BF structures. 
First, we observed an increased qualitative expression of IGF1 in APP/PS1 BF 
nuclei compared with the observed in controls (Figure 4.24). 
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  Figure 4.24: IGF1 receptor expression in BF nuclei of control and APP/PS1 mice. 
mice. 
 
 
 
Moreover, we also observed an increased concentration of IGF1 
receptors in VDB/HDB nuclei in the APP/PS1 mice compared with controls 
(Figure 4.25). 
 
 
 
 
88 
 
Figure 4.25: IGF1 receptor expression in VDB/HDB neurons. 
 
 
 
 
 
4.6 IN VITRO EXPERIMENTS 
In this Section we show the results for Aim 4, the study of the effect of 
TDP-43 knockout in BV2 cells and primary microglia, as part of the toxicity study. 
 
 
4.6.1. EXPERIMENT 1 (IN VITRO): BV2 CELLS 
First we would like to study if the TDP43 oli size was a main important 
factor in for the agregattion inside the cells both in starved and fed conditions in 
the culture. 
 
4.6.1.1 Western Blot (WB) 
siRNA transfection in BV2 cells was done to knockout TDP43. The oligo 1 
and 2 result in reduction of TDP43 in both STARVED and FED condition. In 
contrast, oligo3 and oligo4 show no diference with control group in STARVED and 
FED conditions. TDP pool lead to reduction in all of the cases GAPDH and β-actin 
are equally distribuded in membrane. Thus, we can conclude that the loading 
amount of the protein was identical and the knockout effeciency is demonstrated 
in TDP pool, oligo1 and oligo2, but not in oligo3 and oligo4 (Figure 4.28).  
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Figure 4.26 Western Blot in GS and TDP knockout and GAPDH. 
 
 
 
4.6.1.2. MSD Assay 
The MSD assay was analysed for the clearence of Aβ and sAPP from the BV2 
medium. The level of sAPP do not change the concentration in the medium, 
whereas the levels of Aβ are decresed in all cases. The significant reduction of Aβ 
from the medium is detected in all cases of TDP43 knockdown (Figure 4.27). 
 
 
Figure 4.27: MSD assay in BV2 cells in GC controls and TDP knockout 
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4.6.1.3. Alamar Blue Assay 
Positive colorimetric reaction was detected in all wells with BV2 cells. 
Specifically, during the 3 hours of incubation, blue color of the dye has changed to 
purple color. This reaction reflects the metabolic activity of the viable BV2 cells 
(Figure 4.28). 
 
 
 
 
 
 
 
 
 
 
                                      
Figure 4.28: Alamar Blue Assay 
 
 
 
 
4.6.1.4. Confocal microscopy ver si lo meto aquí o mejor en microglia 
Phagocytic assay (on BV2 coverslides) was analysed using 2-photon 
confocal microscopy. Specifically, Lysotracker 561 and Aβ (1hour and 15 minutes 
interval) were studied. In general, lysotracker deposits were more distributed in 
the microglia cells in STARVED medium than FED medium in both GC controls and 
TDP pool knockout. Moreover, TDP pool knockout STARVED has shown the 
highest amount of lysotracker in the microglia (Figures 4.29 and 4.30). 
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Figure 4.29:  Aβ uptake in control (GC) and TDP43 after 1 hour. 
 
 
Figure 4.30:  Lysotracer uptake in GC  and TDP43 in FED conditions. 
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4.6.2. EXPERIMENT 2 (EX VIVO): PRIMARY MICROGLIA  
We monitored the plates under optic microscope after 1.5 hours, 24 hours 
(Figure 4.31) and 3 days (Figure 4.32) of treatment and we observed some 
morfological changes in the cells. Cre treatment rapidly affects microglia 
morphology. There were some vacuoles which disappear 3 days post treatment. 
We also observed thicker processes in the CRE cells comparing to the control. 
 
 
Figure 4.32: 3 days post treatment phenotype. 
 
IF 
Control Cre treated 
Cre treated Contro
l 
Figure 4.31: Vacuoles phenotype 24hrs after treatment. 
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We keep the cells to assess the uptake of the aggregates of TDP43 using 
immunofluorescent staining and we also collected the medium (Kept in -20ºC) for 
fractionation and Western Blot assays. 
 
With these primary microglia cells in the cover slides we performed an 
immunofluorescence assay in order to see the TDP43 aggregates uptake by the 
primary microglia cells. We then studied the slides under confocal microscope. We 
observed a higher uptake of TDP43 oligomers in the CRE treated cells than in the 
controls, and that higher uptake is correlated with the time of the treatment (more 
uptake in the 2 hours than in the 30 minutes) and we also see more uptake with 
the 500nM than with the 100nM concentration of aggregates (Figure 4.33).  
There was not just a global increase in the uptake, but it seems that even if 
there are not more cells uptaking the TDP-43 oligos, once the cells uptake TDP43 
they are uptake it more (they are full of them all over the cytoplasm). Also, the CRE 
treated cells seems to be bigger in size than the control ones. 
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Figure 4.34: Confocal microscope images of primary microglia TDP43 agregated uptake 
in Cre treated conditions.in control conditions. 
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Figure 4.35: Confocal microscope images of primary microglia TDP43 agregated 
uptake in Cre treated conditions. 
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2.2.2 Fraccionation and 2.2.3 Western Blot 
With the TDP43 aggregates medium we did a fractionation and a Western 
Blot for analyzing this media composition (Figure 4.36 and 4.37).  
 
 
These are the images we obtained from the Fiji LAS 4000. We have assessed 
that the aggregates we were using in the medium have two different sizes, 
corresponding to de 100nM and 500nM concentration. We can see in the 
membrane (Picture 13) that the 100nM TDP43 aggregates were smaller so they 
run better in the gel and the 500nM TDP43 aggregates were bigger and they got 
stacked on it. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.40: WB of TDP43 agregates medium in two different concentration.  
a. Corresponds to 100nM, b. Corresponds to 500nM. 
Figure 4.36: Electrophoresis setting. 
b 
a 
b a 
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5. DISCUSSION 
 
In this Thesis, we tested the hypothesis that the specificity of anatomical 
pathways linking the BF nuclei with the cerebral cortex, as well as their functional 
roles may play an important role, since it has been hypothesized that AD 
symptoms may be a consequence of either neuronal loss or impairment of BF 
neurons functionality due to toxicity.  
 
Our main findings showed that the different nuclei of the BF display specific 
projecting pathways to and from the different modalities cortices. The HDB may 
play an important role in the sensory stimuli discrimination due to its segregated 
projecting pathways to the different cortices and also due to a preferential circuit 
which shares with the mPfC. This is not the case of B nucleus which projects 
equally, with no preferential pathways, to all sensory cortices and do not have a B 
nuvleus-mPfC circuit. Moreover, HDB showed many contralateral projections 
which lead us to reinforce our idea of thinking of the HDB, not only as a relay 
station but, as a key point for filtering the sensory inputs. These different patterns 
identified in HDB and B nucleus, might be important in the AD developmental 
stages. We have observed a decrease in the number of cholinergic neurons in both 
HDB and B nucleus, most accused in the B nucleus as previously described also by 
other authors (Whitehouse et al., 1982), We hypothesized that the fact that the 
neuronal lost starts in B could be related with our findings of a higher 
concentration of IGF1 receptor in HDB cholinergic neurons than in B nucleus ones; 
therefore, IGF1 might be playing a protective neuronal role in HDB neurons, and 
these neurons might be compensating the B neuronal lost and masking the AD 
symptoms in first stages of the disease. This neuronal lost as well as symptoms in 
the late stages of AD, might be caused in our agreement of our results, among other 
causes, by the toxicity caused as a result of the aberrant function of TDP43, leading 
to a primary microglia massive activation trying to overcome the malfunction of 
the physiological neuronal metabolism which might be compensated in the first 
stages of AD but leads, when it is too acute, to the neuronal lost and so, to the 
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malfunction of these neuronal pathways causing the characteristic symptoms of 
AD. 
 
A fundamental question at hand in the present study concerns whether the 
BF neuronal population operates more as a unified group, simultaneously 
activating all cortical areas, or instead operates as a set of distinct neuronal groups 
that differentially activate specific cortical regions.  
 
Our results in rodents support the latter possibility since they reveal that the 
BF is a heterogeneous area in which neurons projecting to different cortical areas 
are segregated into different neuronal groups. In both rat and mice, most of the 
HDB has a large number of neurons that project to S1 cortex, indicating that this 
area is specialized in sensory processing of somatosensory stimuli. However, the B 
nucleus shows a similar number of cells projecting to S1 than to A1 and V1 
cortices. Accordingly, optogenetic HDB stimulation induced more extensive 
facilitation of tactile evoked potentials than auditory evoked potentials, while 
optogenetic stimulation of B nucleus facilitated either tactile or auditory evoked 
potentials equally.  
 
We have demonstrated that there is a topographical map linking neurons in 
different BF areas with their targets in primary sensory cortices and mPfC. B 
nucleus projections from the caudal BF to the S1, A1 and V1 cortices are similar in 
importance. In fact, this nucleus exhibits numerous double-labeled neurons, 
suggesting an absence of cortical specificity; however, the S1 and mPfC cortices 
receive major inputs from rostral BF areas, including the VDH and HDB (Figure 
5.1). 
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Figure 5.1: Summary diagram displaying anatomical connections of HDB and B nuclei. 
Results showed that HDB has preferential bidirectional projections (double arrows) to S1 and 
mPfC while the B nucleus projects to all sensory areas in general and does not project to mPfC. 
Green arrows represent double-labeled neurons. Black arrows represent single-labeled 
neurons. 
 
 
Contralateral projections from the BF were mainly found in VDB and HDB 
areas while B nucleus displayed very few contralateral projecting neurons. These 
contralateral projections may serve to synchronize cortical related areas. The ipsi- 
or contralateral projection pattern also reveal that VDB or HDB areas have 
different cortical projections that B and SI areas (Figure 5.2). 
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Figure 5.2: Summary of connections from BF neurons to sensory cortices. 
Schematic diagram summarizes the cortical-BF connections. Yellow circles represent FlGo 
labeled neurons, blue circles represent FB labeled neurons and green circles represent 
double labeled neurons, found in each BF nucleus; colored arrows represent the 
corresponding sensory cortical projection. Yellow ellipsoids represent the injections of 
FlGo in A1, S1 or V1. Blue ellipsoids represent FB deposits in A1, S1 or V1. Dash line 
represents the middle line. Dashes arrows indicate a percentage less than 2% of labeled 
neurons.  
 
 
Cortically projecting neurons in the BF were characterized as cholinergic, 
GABAergic or peptidergic neurons (Fisher et al., 1988, Zaborszky and Duque, 2000, 
Zaborszky et al., 2005, Mascagni and McDonald, 2009). Because cholinergic 
neurons in the BF are scattered among neurons with different neurochemical 
identities, we used optogenetic stimulation of cholinergic neurons in mice to study 
the specific cholinergic effects on sensory cortical responses of the BF-cortical 
circuits observed from the anatomical results. In contrast to the specific facilitation 
of sensory responses, blue light stimulation of either HDB or B nucleus cause 
similar desynchronization of S1 or A1 field potential. Likewise, illumination of 
neocortex desynchronizes the local field potential in the same transgenic, 
anesthetized mice, indicating that light evoked the release of ACh in the cortex 
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(Kalmbach et al., 2012). We have shown that optogenetic stimulation of cholinergic 
HDB neurons facilitated mostly tactile evoked potentials in S1 than auditory 
evoked potentials in A1 cortex. Thus, our results support a localized cortical effect 
of cholinergic projections. In contrast, optogenetic stimulation of B neurons 
facilitated auditory and tactile evoked potentials in the same proportion. In 
agreement with our data, optogenetic activation of BF cholinergic axons in visual 
cortex enhances performance of a visual discrimination task, while silencing BF 
cholinergic cells impaired performance (Pinto et al., 2013). 
 
 In the cases of rats experiments, using BF focal virus injections to express 
channel rhodopsin (ChR2), we confirming the results obtained in mice, that S1 
whisker responses were mainly modulated by the HDB because optogenetic 
stimulation of HDB neurons induced important changes in whisker responses by 
S1 and mPfC neurons whereas the changes in cortical responses after optogenetic 
stimulation of the B nucleus were less evident. Most of these effects were due to 
activation of the cholinergic neurons since they were blocked by intraperitoneally 
injected nicotinic or muscarinic receptor antagonists. This BF-mPfC anatomical 
pathway seems to be very specific since projections to cortical areas mainly arise 
from specific neuronal groups, as supported by the observation that most of the 
HDB neurons were single-labeled after a cortical injection of retrograde tracer. 
Thus, it is reasonable to think that the pathway linking HDB-primary sensory 
cortices-mPfC and back to BF may be relevant in the specific sensory processing 
that is required for attention or learning processes. In contrast, using the same 
experimental protocol of retrograde tracer injection, the B nucleus showed a large 
proportion of double-labeled cortical neurons, showing that the B nucleus is non-
specifically connected to sensory areas in general and is not directly related with 
mPfC. Moreover, the B nucleus also connected to the M1 cortex, suggesting that 
this pathway may be involved in sensory-motor coordination. Accordingly, the 
anatomical specificity described here has also been observed in the neuronal 
activation of prefrontal cortex-projecting vs. motor cortex-projecting BF neurons 
during task performance (Parikh et al., 2007). Thus, B nucleus neurons may 
integrate information necessary for sensory-motor modulation from the striatum 
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(Hu et al., 2016) given their significant projections to M1 and primary sensory 
cortices. 
These findings suggest that a large population of cholinergic BF neurons is 
involved in cortical activation but, the cholinergic modulation of sensory responses 
is account from specific groups of neurons. In this process, might contribute ipsi- 
and contralateral projections cooperatively. In agreement with the existence of 
two functional roles of cholinergic BF pathways, micro dialysis studies in the 
medial prefrontal cortex have reported a tonic ACh increase during attention-
related performance tasks (Passetti et al., 2000), that may promote a general state 
of cortical arousal (EEG desynchronization). Moreover, ACh can also be released 
briefly (phasic release) in concert with cue detection in a cued appetitive response 
task to facilitate specific information processing (Parikh et al., 2007). Thus, phasic 
release of ACh would support more rapid transitions of cortical states, consistent 
with cholinergic regulation of attention to relevant stimuli, while a sustained ACh 
release could promote a general state of cortical activation (see (Luchicchi et al., 
2014, Sarter et al., 2014). Our results support these findings and suggest that 
different BF cholinergic neurons may play these different roles. 
Based on these anatomical findings, the control of cortical processing by 
projections from given cholinergic areas in the BF could be much more specific 
than traditionally thought because our results reveal that the networks formed by 
BF-cortical bidirectional connections are specific to certain functions. 
 
Different anatomical techniques have been used to map anatomical 
projections from the BF to different cortical areas (Bigl et al., 1982; Price and Stern, 
1983; Zaborszky et al., 1986, 1999; Gritti et al., 1997, 2003; Zaborszky, 2002; 
Zaborszky et al., 2005, 2015; Nadasdy et al., 2010; Bloem et al., 2014). These 
studies have demonstrated the rostro-caudal distribution of neurons with different 
afferent and efferent inputs (also confirmed by present results). Furthermore, we 
provide novel information about the relationship between the location of BF 
neurons and their targets in the primary sensory and mPfC cortices. Present data 
also corroborate that these targets are integrated in distinct BF-cortical networks 
that may play different roles in sensory processing, motor control, or cortical 
arousal.  
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The bidirectional connectivity between mPfC and BF has attracted great 
interest as a circuit that is involved in modulating decision making, cortical 
arousal, and learning and memory (Groenewegen and Uylings, 2000; Miller and 
Cohen, 2001; Dalley et al., 2004; Henny and Jones 2008; Wise, 2008; Ramanathan 
et al., 2009; Martinowich et al., 2012; Paolone et al., 2012; Bloem et al., 2014; 
Zaborszky et al., 2015). The connections between the mPfC and other cortical areas 
that apparently contribute to information processing seem to be specific 
topographically organized (Hoover and Vertes, 2007; Bedwell et al., 2014; Bedwell 
et al., 2015; Zaborszky et al., 2015). The bidirectional projections between BF and 
mPfC described here are located so as to shape cortical activity (Schwierin et al., 
1999; Massimini et al., 2004). In such processes, the cholinergic, GABAergic and 
glutamatergic BF neuronal groups or subgroups probably play diverse and 
complementary roles. Our results indicate that these projecting neurons are 
mainly concentrated in the rostral BF, including VDB and HDB. Their activation by 
optogenetic stimulation induced an important facilitation of whisker responses in 
S1. This response facilitation was due to activation of muscarinic receptors since it 
was blocked by the previous injection of atropine. However, the same projection 
inhibited whisker responses in mPfC though activation of nicotinic receptors since 
the inhibition could be abolished by mecamylamine. 
 
The topography of BF projections to the cortex is an important issue because 
it might indicate in what manner the cholinergic BF system participates in cortical 
sensory processing. Probably, this finding is due to the importance of the whisker 
sensory system in rodents, giving greater evidence of the existence of neuronal 
clusters involved in the information processing of somatosensory stimuli. 
However, this pattern of projection could occur in other sensory systems although 
they were less evident. In fact, the cholinergic neurons that project to V1 are 
located in the BF, particularly the ventral pallidum, SI and the HDB (Gaykema et al., 
1990, Laplante et al., 2005). Although the B nucleus is one of the main cholinergic 
nucleus of the BF, it projects weakly to V1 (Luiten et al., 1987, Vaucher and Hamel, 
1995), as also occur in our experiments. In this regard, Záborszky et al. (2013) 
have demonstrated that the cholinergic and non-cholinergic pathways to the 
cortex are organized into segregated or overlapping pools of projection neurons. 
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The extent of overlap between BF populations projecting to the cortex depends on 
the degree of connectivity between the cortical targets of these projection 
populations.  
 
Previous reports have indicated regional differences in the regulation of 
cortical ACh release. This has been demonstrated in a neurophysiological 
experiment wherein differential modulation of somatosensory and visual cortices 
to tactile and visual stimuli, respectively, resulted from activation of neighboring 
BF neurons (Golmayo et al., 2003). Moreover, they proposed that the BF could be 
an anatomical and functional relay between the prefrontal cortex and sensory 
cortical areas. Regionally specific activation of ACh release has been also 
demonstrated in V1 and S1 cortices following presentation of either visual or 
somatosensory stimuli (Fournier et al., 2004, Laplante et al., 2005). Taken together 
these results suggest that cortical ACh release is increased with regional specificity 
in response to a finely tuned sensory stimulus in urethane-anesthetized animals. 
This modality-specific activation is supported by the topographical projections 
from BF to sensory cortices (Zaborszky, 2002, Zaborszky et al., 2005, Zaborszky et 
al., 2013). Anatomical specificity has also been observed in the activation of 
prefrontal cortex-projecting vs. motor cortex-projecting BF cholinergic neurons 
during task performance (Parikh et al., 2007). These findings suggest the existence 
of different subpopulations of BF neurons involved in the modulation of specific 
tasks. Accordingly, clustering techniques applied to unit recordings of BF neurons 
during different attentional tasks have revealed many distinct categories of task-
phase-specific activity patterns in the BF neurons (Tingley et al., 2014). 
Consequently, results strongly suggest the existence of neuronal populations in the 
BF that are involved in modulation of sensory cortical response, as has been 
published recently in the somatosensory cortex (Barros-Zulaica et al., 2014, 
Martin-Cortecero and Nuñez, 2014).  
 
The BF is recognized as an important site of sleep-wake regulation (Koyama, 
2012; Kalinchuk et al., 2015); actually, BF receives wide-spread input from 
hypothalamic nuclei, including the preoptic areas and lateral hypothalamic area, 
both of which are implicated in sleep and arousal regulation (Szymusiak et al., 
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2007; Hu et al., 2016). Our results, showing a large number of double-labeled 
neurons, which projects simultaneously to different cortical areas suggest that the 
B nucleus is in the best nodal point to control arousal level. Our results also show 
that SI had a similar connection pattern that of the B nucleus. Recently, it has been 
published that orexinergic neurons, which play an essential role in promoting 
arousal, have strong reciprocal connections with SI neurons (Agostinelli et al., 
2017); thus, SI and orexin neurons probably work in concert to promote arousal. 
 
So far, concerning our anatomical studies and results of the BF-cortical 
circuits and its characteristic features, we can propose that complex behaviors 
require the integration of different synaptic inputs in the brain. These functions 
cannot be performed using the traditional description of the FB cholinergic system 
as a diffusely organized neuromodulator system with widespread influence on 
information processing across large portions of the cortex. Recent evidence 
supports an alternative hypothesis that proposes that the cognitive functions of 
cholinergic projections are determined in part by BF-cortical circuitry controlling 
cholinergic synaptic neurotransmission release in a more specific manner than 
previously assumed (Hasselmo and Sarter, 2011; Zaborsky et al., 2015). Our 
results agree with this alternative hypothesis and further suggest that the cortex 
and BF are integrated in specific neuronal networks with different roles in sensory 
processing, motor planning or arousal control.  
 
Taken together, previous and present results indicate that stimulus evoked 
responses HDB corticofugal neurons can contribute to sensory processing by 
selecting different cortices responses as preferred or non-preferred inputs, in a 
modality-specific manner, contributing to the perception of specifically sensory 
information. In a same manner, contralateral projections may play an important 
role in sensory inputs processing.  
 
 Once we concluded that BF-cortical circuitry may be implicated in 
the integration and processing of specific sensory input processing, we now focus 
on the results concerning the BF cholinergic neuronal implication in Alzheimer´s 
Disease model and the role of neuronal death and toxicity in its pathogenesis. Our 
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results showed a decrease in the number of cholinergic neurons in B nucleus 
(Cantero et al., 2016) but also in HDB. This neuronal lost is more acute in females 
than in males. IGF1 is demonstrated to be implicated in long term potentiation 
process, facilitates sensory processing in the cortex and enhances EEG activity 
(Trueba et al 2013; Nishijima et al 2010), and BF cholinergic neurons induce 
cortical activation and facilitates sensory processing (Oldford and Castro-
Alamancos 2003; Sarter et al 2009). We observed an increased amount of IGF1 
receptor in the HDB of APP/PS1 mice compared with control. That could explain 
the initial neuronal lost in B nucleus but not in HDB since IGF1 may be playing a 
protective role of these neurons which presents higher concentration of IGF1 
receptor. In this way, in the first stages of AD, when there is neuronal lost in B 
nucleus, the HDB projecting circuits, which have more specific targets, may be 
overtaking the functional roles of these death neurons in B nucleus. Moreover, in 
our opinion, the neuronal death might be a consequence of the neuronal toxicity 
gain. We support this hypothesis by our in vitro results. We have studied, in 
microglia and BB2 cells, the role of TDP43 and its implication in the possible 
involvement in Alzheimer’s disease. Two different experiments were performed 
with different approaches. First in vitro experiment studied the BV2 cells where 
the knockout was induced by siRNA transfection. The second experiment studied 
the role of TDP43 in primary microglia isolated from loxP/loxP knockout mice. The 
efficiency of the knockdown in BV2 cells was studied by WB and reveal the 
reduction of TDP43 in TDP pool, oligo1, oligo2, but not oligo3, oligo4. Hovewer, 
our preliminary results show the increased phagocytosis of Aβ and lysotracer in 
BV2 as well as TDP oligomers in PM in all cases. Lysotracer is acknowledged as an 
indicator of acidic structures in the cells. Specifically, the increased amount of 
lysotracer in the cells corresponds with increased activity of lysosomes and late 
endosomes. Additionally, the phagocytosis was attenuated with higher doses 
and/or with increased time in both experiments. The increased clearance of Aβ in 
all knockout samples also corresponded with our previous results and may reflect 
the increased removal of Aβ from the cells. Conclusively, establishing the direct 
link between TDP43 and AD has not been easy. The principal difficulty comes from 
the huge number of processes that can be aberrantly affected by TDP43 
aggregations in neurons and microglia, and by the nuclear depletion of TDP43. The 
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basic characteristics of TDP43 should be considered because they may ultimately 
control the disease. The balance between such complicated processes should be 
the aim of further research (the effect of intracellular inclusions in the gain of 
toxicity or loss of function, phagocytosis resulting in increased removal of amyloid 
plaques or dendritic spines) 
 
All the above mentioned could lead to a gain of neuronal toxicity which 
might leads to the death or loss of function of the neurons. HDB projecting neurons 
(both ipsi and contralateral) could be important in the AD during first stages of the 
disease due to their specific projection circuits patterns. In contrast, B nucleus, 
since it is not displaying specific circuits but spread-wide projecting pathways to 
all the modality cortices but the mPfC, might not be playing a decisive role in 
sensory input discrimination. Moreover, taking into account first, the specificity in 
projecting circuits in HDB but not in B nucleus, second, that we observed increased 
levels of IGF1 receptor in cholinergic neurons of HDB than in B nucleus, and third 
that the neuronal lost its observed in B nucleus in the first stages of AD when 
attention, learning and memory is not affected yet, those three facts leads us to 
think about the importance of HDB in the facilitation of a specific information 
processing. This could be implicated in dysfunctional sensory-motor integration 
and in AD pathological stages (Butcher and Woolf, 2004; Ballinger et al, 2016). 
Thereby, the neuronal circuits are not working as in physiological conditions. In 
the first stages of the disease that might be able to be compensated between 
neuronal circuits of B and HDB acquiring the functions of B nucleus ones. That 
could explain the progress of the AD symptoms, since in early stages of the disease, 
learning, attention and memory are not affected, corresponding that with the 
integrity of the mPfC-HDB-sensory cortices circuits we have described, but, leading 
in late stages of the disease when we observed also neuronal lost in HDB, with the 
characteristic features of AD symptoms. 
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6. CONCLUSIONS 
 
1. The Basal Forebrain in rodents is a heterogeneous area in which 
there are segregated neurons in different neuronal groups that 
project to different circuits. 
 
 
2. Most HDB neurons project to the S1 cortex, indicating that this area 
must be specialized in the processing of the tactile stimuli, while the 
nucleus B shows a similar proportion of neurons projecting both S1 
and A1. 
 
 
3. The optogenetic stimulation of the cholinergic neurons of the 
different nuclei of the BF evokes different sensory responses in the 
different crusts. 
 
 
4. Cholinergic projections to the cortex are organized into segregated 
groups of neurons that could modulate specific cortical areas. 
 
 
5. The modulation carried out by the BF in the sensory cortex goes 
through separated channels from HDB, however the modulation 
carried out by the B neurons is by both separate and joint pathways. 
 
 
6. The neurons of the prefrontal cortex maintain a preferential 
reciprocal circuit with HDB but not with B. 
 
 
7. IGF1 levels are higher in HDB neurons in APP / PS1 than the AD model 
with respect to controls. 
 
 
8. TDP-43 could play an important role in the development of AD 
pathogenesis. 
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7. CONCLUSIONES 
 
1. El BF en roedores es un área heterogénea en la cual existen neuronas 
segregadas en diferentes grupos neuronales que proyectan a distintas 
cortezas. 
 
 
2. La mayoría de neuronas localizadas en HDB proyectan a la corteza S1, 
indicando que éste área debe estar especializada en el procesamiento 
de los estímulos táctiles, mientras que el núcleo B muestra una 
proporción similar de neuronas que proyectan tanto a S1 como a A1. 
 
 
3. La estimulación optogenética de las neuronas colinérgicas de los 
distintos núcleos del BF evoca distintas  respuestas sensoriales en las 
diferentes cortezas.  
 
 
4. Las proyecciones colinérgicas a la corteza están organizadas en 
grupos segregados de neuronas que podrían modular áreas corticales 
específicas.  
 
 
5. LA modulación llevada a cabo por el BF en las cortezas sensoriales va 
por vías separadas desde HDB, sin embargo la modulación llevada a 
cabo por las neuronas de B es mediante vías tanto separadas como 
conjuntas. 
 
 
6. Las neuronas de la corteza prefrontal mantienen un circuito 
recíproco preferencial con HDB pero no con B. 
 
7. Los niveles de IGF1 son más elevados en neuronas del HDB en el 
APP/PS1 del modelo de AD con respecto a los controles. 
 
 
8. TDP-43 podría tener un papel importante en el desarrollo de la 
patogénesis de la AD. 
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